0000350868false03-312025Q1P2YP2Yoneonehttp://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrentoneone90xbrli:sharesiso4217:USDiso4217:USDxbrli:sharesiti:segmentxbrli:pureiti:planiti:offering_period00003508682024-04-012024-06-3000003508682024-08-0200003508682024-06-3000003508682024-03-310000350868us-gaap:ProductMember2024-04-012024-06-300000350868us-gaap:ProductMember2023-04-012023-06-300000350868us-gaap:ServiceMember2024-04-012024-06-300000350868us-gaap:ServiceMember2023-04-012023-06-3000003508682023-04-012023-06-3000003508682023-03-3100003508682023-06-300000350868us-gaap:CommonStockMember2024-03-310000350868us-gaap:TreasuryStockCommonMember2024-03-310000350868us-gaap:AdditionalPaidInCapitalMember2024-03-310000350868us-gaap:RetainedEarningsMember2024-03-310000350868us-gaap:CommonStockMember2024-04-012024-06-300000350868us-gaap:AdditionalPaidInCapitalMember2024-04-012024-06-300000350868us-gaap:TreasuryStockCommonMember2024-04-012024-06-300000350868us-gaap:RetainedEarningsMember2024-04-012024-06-300000350868us-gaap:CommonStockMember2024-06-300000350868us-gaap:TreasuryStockCommonMember2024-06-300000350868us-gaap:AdditionalPaidInCapitalMember2024-06-300000350868us-gaap:RetainedEarningsMember2024-06-300000350868us-gaap:CommonStockMember2023-03-310000350868us-gaap:TreasuryStockCommonMember2023-03-310000350868us-gaap:AdditionalPaidInCapitalMember2023-03-310000350868us-gaap:RetainedEarningsMember2023-03-310000350868us-gaap:CommonStockMember2023-04-012023-06-300000350868us-gaap:AdditionalPaidInCapitalMember2023-04-012023-06-300000350868us-gaap:RetainedEarningsMember2023-04-012023-06-300000350868us-gaap:CommonStockMember2023-06-300000350868us-gaap:TreasuryStockCommonMember2023-06-300000350868us-gaap:AdditionalPaidInCapitalMember2023-06-300000350868us-gaap:RetainedEarningsMember2023-06-300000350868srt:MinimumMemberus-gaap:MachineryAndEquipmentMember2024-06-300000350868srt:MaximumMemberus-gaap:MachineryAndEquipmentMember2024-06-300000350868srt:MinimumMember2024-06-300000350868srt:MaximumMember2024-06-300000350868us-gaap:EquipmentMember2024-06-300000350868us-gaap:EquipmentMember2024-03-310000350868us-gaap:LeaseholdImprovementsMember2024-06-300000350868us-gaap:LeaseholdImprovementsMember2024-03-310000350868us-gaap:DevelopedTechnologyRightsMember2024-06-300000350868us-gaap:DevelopedTechnologyRightsMember2024-03-310000350868iti:CustomerContractsAndRelationshipMember2024-06-300000350868iti:CustomerContractsAndRelationshipMember2024-03-310000350868iti:TradeNamesAndNoncompeteAgreementsMember2024-06-300000350868iti:TradeNamesAndNoncompeteAgreementsMember2024-03-310000350868us-gaap:SoftwareAndSoftwareDevelopmentCostsMember2024-06-300000350868us-gaap:SoftwareAndSoftwareDevelopmentCostsMember2024-03-310000350868us-gaap:CostOfSalesMember2024-04-012024-06-300000350868us-gaap:CostOfSalesMember2023-04-012023-06-300000350868us-gaap:OperatingExpenseMember2023-04-012023-06-300000350868us-gaap:OperatingExpenseMember2024-04-012024-06-300000350868iti:EmployeeAndNonEmployeesStockOptionMember2024-04-012024-06-300000350868iti:EmployeeAndNonEmployeesStockOptionMember2023-04-012023-06-300000350868us-gaap:RestrictedStockUnitsRSUMember2024-04-012024-06-300000350868us-gaap:RestrictedStockUnitsRSUMember2023-04-012023-06-300000350868us-gaap:FairValueInputsLevel1Memberiti:SecuritiesHeldInDeferredCompensationPlanMember2024-06-300000350868us-gaap:FairValueInputsLevel1Memberiti:DeferredCompensationPlanLiabilitiesMember2024-06-300000350868us-gaap:FairValueInputsLevel1Memberiti:SecuritiesHeldInDeferredCompensationPlanMember2024-03-310000350868us-gaap:FairValueInputsLevel1Memberiti:DeferredCompensationPlanLiabilitiesMember2024-03-3100003508682023-08-072023-08-070000350868iti:OmnibusIncentivePlan2016Member2024-06-300000350868iti:EmployeeAndNonEmployeesStockOptionMember2024-03-310000350868iti:EmployeeAndNonEmployeesStockOptionMember2024-04-012024-06-300000350868iti:EmployeeAndNonEmployeesStockOptionMember2024-06-300000350868us-gaap:RestrictedStockUnitsRSUMember2024-04-012024-06-300000350868us-gaap:RestrictedStockUnitsRSUMember2024-03-310000350868us-gaap:RestrictedStockUnitsRSUMember2024-06-300000350868us-gaap:PerformanceSharesMembersrt:MinimumMember2024-04-012024-06-300000350868us-gaap:PerformanceSharesMembersrt:MaximumMember2024-04-012024-06-300000350868us-gaap:PerformanceSharesMember2024-04-012024-06-300000350868us-gaap:PerformanceSharesMember2024-03-310000350868us-gaap:PerformanceSharesMember2024-06-300000350868us-gaap:GeneralAndAdministrativeExpenseMember2024-04-012024-06-300000350868us-gaap:GeneralAndAdministrativeExpenseMember2023-04-012023-06-300000350868us-gaap:SellingAndMarketingExpenseMember2024-04-012024-06-300000350868us-gaap:SellingAndMarketingExpenseMember2023-04-012023-06-300000350868us-gaap:ResearchAndDevelopmentExpenseMember2024-04-012024-06-300000350868us-gaap:ResearchAndDevelopmentExpenseMember2023-04-012023-06-300000350868us-gaap:PhantomShareUnitsPSUsMember2024-06-300000350868us-gaap:PhantomShareUnitsPSUsMember2024-04-012024-06-300000350868us-gaap:EmployeeStockMember2024-04-012024-06-300000350868us-gaap:EmployeeStockMembersrt:MinimumMember2024-04-012024-06-300000350868us-gaap:EmployeeStockMembersrt:MaximumMember2024-04-012024-06-3000003508682020-10-010000350868iti:StockRepurchaseProgramMay2022Member2022-05-120000350868iti:StockRepurchaseProgramMay2022Member2024-04-012024-06-300000350868iti:StockRepurchaseProgramMay2022Member2022-05-122024-06-300000350868iti:StockRepurchaseProgramMay2022Member2024-06-300000350868iti:JoeBergeraMember2024-04-012024-06-300000350868iti:JoeBergeraMember2024-06-30
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
________________________________________________________________________________
Form 10-Q
(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2024
OR
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from                  to                     
Commission file number: 001-08762
iterislogo.jpg
ITERIS, INC.
(Exact name of registrant as specified in its charter)

Delaware
(State or other jurisdiction of
incorporation or organization)
1250 S. Capital of Texas Hwy., Building 1, Suite 330
Austin, Texas
(Address of principal executive office)
95-2588496
(I.R.S. Employer
Identification No.)
78746
(Zip Code)

(512) 382-9669
(Registrant’s telephone number, including area code)

(Former address, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, $0.10 par valueITIThe Nasdaq Stock Market LLC
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filerAccelerated filerNon-accelerated filerSmaller reporting company
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  No x
As of August 2, 2024, there were 42,822,824 shares of our common stock outstanding.


ITERIS, INC.
Quarterly Report on Form 10-Q
Table of Contents
UNAUDITED CONDENSED BALANCE SHEETS AT JUNE 30, 2024 AND MARCH 31, 2024
UNAUDITED CONDENSED STATEMENTS OF INCOME FOR THE THREE MONTHS ENDED JUNE 30, 2024 AND 2023
UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS FOR THE THREE MONTHS ENDED JUNE 30, 2024 AND 2023

Unless otherwise indicated in this report, the “Company,” “we,” “us” and “our” refer to Iteris, Inc. ClearMobility®, Iteris®, and Vantage® are among, but not all of, the trademarks of Iteris, Inc. Any other trademarks or trade names mentioned herein are the property of their respective owners.


PART I. FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
Iteris, Inc.
Unaudited Condensed Balance Sheets
(In thousands, except par values)
June 30,
2024
March 31,
2024
Assets
Current assets:
Cash and cash equivalents$21,377 $25,850 
Restricted cash248 125 
Trade accounts receivable, net of allowance for doubtful accounts of $281 and $351 at June 30, 2024 and March 31, 2024, respectively
30,635 25,672 
Unbilled accounts receivable8,386 7,271 
Inventories14,841 13,432 
Prepaid expenses and other current assets3,418 3,581 
Total current assets78,905 75,931 
Property and equipment, net1,288 1,296 
Right-of-use assets6,827 7,237 
Intangible assets, net8,791 9,602 
Goodwill28,340 28,340 
Other assets1,084 1,039 
Total assets$125,235 $123,445 
Liabilities and stockholders’ equity
Current liabilities:
Trade accounts payable$17,100 $15,852 
Accrued payroll and related expenses13,070 12,812 
Accrued liabilities6,535 6,596 
Deferred revenues7,859 8,070 
Total current liabilities44,564 43,330 
Lease liabilities5,857 6,210 
Deferred income taxes538 515 
Unrecognized tax benefits39 39 
Other long-term liabilities3,954 3,444 
Total liabilities54,952 53,538 
Commitments and contingencies (Note 5)
Stockholders’ equity:
Preferred stock, $1.00 par value:
Authorized shares — 2,000
Issued and outstanding shares — none
  
Common stock, $0.10 par value:
Authorized shares - 70,000 at June 30, 2024 and March 31, 2024
Issued and outstanding shares — 43,006 at June 30, 2024 and 42,972 at March 31, 2024
4,301 4,298 
Treasury stock(29)(15)
Additional paid-in capital194,695 194,093 
Accumulated deficit(128,684)(128,469)
Total stockholders' equity70,283 69,907 
Total liabilities and stockholders' equity$125,235 $123,445 

See accompanying Notes to Unaudited Condensed Financial Statements
1

Iteris, Inc.
Unaudited Condensed Statements of Income
(In thousands, except per share amounts)
Three Months Ended
June 30,
20242023
Product revenues$24,396 $23,658 
Service revenues21,381 19,887 
Total revenues45,777 43,545 
Cost of product revenues13,171 12,104 
Cost of service revenues15,266 14,638 
Cost of revenues28,437 26,742 
Gross profit17,340 16,803 
Operating expenses:
General and administrative6,306 5,801 
Sales and marketing7,250 6,290 
Research and development2,880 2,108 
Amortization of intangible assets651 651 
Total operating expenses17,087 14,850 
Operating income253 1,953 
Non-operating income:
Other income, net56 199 
Interest income, net131 68 
Income before income taxes440 2,220 
Provision for income taxes(48)(95)
Net income$392 $2,125 
Net income per common share
     Basic net income per share $0.01 $0.05 
     Diluted net income per share $0.01 $0.05 
Shares used in basic per share calculations42,969 42,567 
Shares used in diluted per share calculations43,970 43,640 

See accompanying Notes to Unaudited Condensed Financial Statements
2

Iteris, Inc.
Unaudited Condensed Statements of Cash Flows
(In thousands)
Three Months Ended
June 30,
20242023
Cash flows from operating activities
Net income$392 $2,125 
Adjustments to reconcile net income to net cash (used in) provided by operating activities:
Right-of-use asset non-cash expense539 511 
Deferred income taxes23 22 
Depreciation of property and equipment135 150 
Stock-based compensation595 525 
Amortization of intangible assets982 783 
Changes in operating assets and liabilities:
Trade accounts receivable(4,963)(1,620)
Unbilled accounts receivable and deferred revenues(816)687 
Inventories(1,409)(693)
Prepaid expenses and other assets118 (1,182)
Trade accounts payable and accrued expenses1,268 3,354 
Operating lease liabilities(482)(616)
Net cash (used in) provided by operating activities(3,618)4,046 
Cash flows from investing activities
Purchases of property and equipment(24)(168)
Capitalized software development costs(97)(588)
Net cash used in investing activities (121)(756)
Cash flows from financing activities
Proceeds from stock option exercises10 257 
Tax withholding payments for net share settlements of performance stock units (6)
Repurchases of common stock(621) 
Net cash (used in) provided by financing activities(611)251 
(Decrease) increase in cash, cash equivalents and restricted cash(4,350)3,541 
Cash, cash equivalents and restricted cash at beginning of period25,975 16,727 
Cash, cash equivalents and restricted cash at end of period$21,625 $20,268 
Supplemental schedule of non-cash investing and financing activities:
Lease liabilities arising from obtaining right-of-use assets$129 $121 
Purchases of fixed assets in accounts payable$103 $ 
Capitalized software development costs in accounts payable and accrued liabilities$74 $234 

See accompanying Notes to Unaudited Condensed Financial Statements
3

Iteris, Inc.
Unaudited Condensed Statements of Stockholders’ Equity
(In thousands)

THREE MONTHS ENDED JUNE 30, 2024
Common StockTreasury StockAdditional
Paid-In
Capital
Accumulated
Deficit
Total
Stockholders'
Equity
SharesAmountSharesAmount
Balance at March 31, 202442,972 $4,298 148 $(15)$194,093 $(128,469)$69,907 
Stock option exercises3 — — — 10 — 10 
Issuance of shares pursuant to vesting of performance stock units, net of payroll withholding taxes31 3 — — (3)—  
Stock-based compensation— — — — 595 — 595 
Treasury stock purchases— — 147 (14)— (607)(621)
Net income
— — — — — 392 392 
Balance at June 30, 202443,006 $4,301 295 $(29)$194,695 $(128,684)$70,283 


THREE MONTHS ENDED JUNE 30, 2023
Common StockTreasury StockAdditional
Paid-In
Capital
Accumulated
Deficit
Total
Stockholders'
Equity
SharesAmountSharesAmount
Balance at March 31, 202342,808 $4,282 369 $(891)$190,082 $(130,567)$62,906 
Stock option exercises60 6 — — 251 — 257 
Issuance of shares pursuant to vesting of restricted stock units, net of payroll withholding taxes1 — — — (6)— (6)
Stock-based compensation— — — — 525 — 525 
Net income— — — — — 2,125 2,125 
Balance at June 30, 202342,869 $4,288 369 $(891)$190,852 $(128,442)$65,807 

See accompanying Notes to Unaudited Condensed Financial Statements
4

Iteris, Inc.
Notes to Unaudited Condensed Financial Statements
June 30, 2024
1.Description of Business and Summary of Significant Accounting Policies
Description of Business
Iteris, Inc. (referred to in this report as “Iteris”, the “Company”, “we”, “our”, and “us”) is a provider of smart mobility infrastructure management solutions. Our cloud-enabled solutions help public transportation agencies, municipalities, commercial entities and other transportation infrastructure providers monitor, visualize, and optimize mobility infrastructure to make mobility safe, efficient and sustainable for everyone.
As a pioneer in intelligent transportation systems (“ITS”) technology, our intellectual property, advanced detection sensors, mobility and traffic data, software-as-a-service (“SaaS”) and data-as-a-service ("DaaS") offerings, mobility consulting services, and cloud-enabled managed services represent a comprehensive range of smart mobility infrastructure management solutions that we distribute to customers throughout the United States (“U.S.”) and internationally.
We believe our products, solutions and services increase vehicle and pedestrian safety and decrease congestion within our communities, while also reducing environmental impact, including carbon emissions.
We continue to make significant investments to leverage our existing technologies and further enhance our advanced detection sensors, software as a service portfolio, mobility data sets, mobility consulting services, and cloud-enabled managed services. As we are always mindful of capital allocation, we apply significant effort to evaluate and prioritize these investments. Likewise, we are always exploring strategic alternatives intended to optimize the value of our Company.
Iteris was incorporated in Delaware in 1987 and has operated in its current form since 2004. Our principal executive offices are located at 1250 S Capital of Texas Hwy, Bldg. 1, Suite 330, Austin TX 78746, and our telephone number at that location is (512) 716-0808. Our website address is www.iteris.com. The inclusion of our website address in this report does not include or incorporate by reference into this report any information on, or accessible through, our website. Each of our annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K, together with amendments to these reports, are available on the “Investor Relations” section of our website, free of charge, as soon as reasonably practicable after such material is filed with, or furnished to, the U.S. Securities and Exchange Commission (“SEC”).
Basis of Presentation
Our unaudited condensed financial statements have been prepared in accordance with the rules of the SEC for interim reporting, which permit certain footnotes or other financial information that are normally required by generally accepted accounting principles in the U.S. (“GAAP”) to be condensed or omitted. These unaudited condensed financial statements should be read in conjunction with the Company’s audited financial statements and related notes included in its Annual Report on Form 10-K for Fiscal 2024, filed with the SEC on June 13, 2024, as amended on July 29, 2024. All intercompany accounts and transactions have been eliminated in consolidation. The results of operations for the three months ended June 30, 2024 are not necessarily indicative of the results to be expected for fiscal year ended March 31, 2025 (“Fiscal 2025”) or any other future periods.
Use of Estimates
The preparation of unaudited financial statements in conformity with GAAP requires our management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. Significant estimates made in the preparation of the financial statements include, but are not limited to, recoverability of long-lived and intangible assets; estimates of future cash flows used to assess the recoverability of the impairment of goodwill; projections of taxable income used to assess realizability of deferred tax assets; warranty reserves; costs to complete long-term contracts; indirect cost rates used in cost plus contracts; fair value of stock option awards and equity instruments; and capitalization and estimated useful life of the Company’s internal-use software development costs. Estimates are based on historical experience and on various assumptions that the Company believes are reasonable under current circumstances. However, future events are subject to change and best estimates and judgments may require further adjustments, therefore, actual results could differ materially from those estimates. Management periodically evaluates such estimates, and they are adjusted prospectively based upon such periodic evaluation.
5

Revenue Recognition
Our revenue arrangements are complex in nature and require significant judgment in determining the performance obligation structure. Each contract is unique in nature and therefore is assessed individually for appropriate accounting treatment.
Revenues are recognized when control of the promised goods or services is transferred to our customers, in an amount that reflects the consideration to which we expect to be entitled in exchange for those goods or services. We generate all of our revenues from contracts with customers, ranging from purchase orders to multi-year agreements.
Product revenue-related contracts with customers begin when we acknowledge a purchase order for a specific customer order of product to be delivered in the near term. These purchase orders are generally short-term in nature. Product revenues are recognized at a point in time upon shipment or upon customer receipt of the product, depending on shipping terms. The Company determined that this method best represents the transfer of goods as transfer of control typically occurs upon shipment or upon customer receipt of the product.
Service revenues include revenues derived from the use of the Company’s service platforms and application programming interfaces on a subscription basis as well as from maintenance and support. We generate these revenues from monthly active user fees, SaaS fees, hosting and storage fees, and maintenance and support fees. In most cases, the subscription or transaction arrangement is a single performance obligation comprising a series of distinct services that are substantially the same and that have the same pattern of transfer (i.e., distinct days of service). The Company applies a time-based measure of progress to the total transaction price, which results in ratable recognition over the term of the contract. The Company determined that this method best represents the transfer of services in these situations as the customer obtains equal benefit from the service throughout the service period.
Service revenues are also derived from engineering and consulting service contracts with governmental agencies. These contracts generally include performance obligations in which control is transferred over time. For fixed fee contracts, we recognize revenues over time using the proportion of actual costs incurred to the total costs expected to complete the contract performance obligation. The Company determined that this method best represents the transfer of services as the proportional cost incurred closely depicts the efforts or inputs completed towards the satisfaction of a fixed fee contract performance obligation. Other contracts can be based on a Time & Materials (“T&M”) and Cost Plus Fixed Fee (“CPFF”) structure, where such contracts are considered to involve variable consideration. However, contractual performance obligations with these fee types qualify for the “Right to Invoice” practical expedient. Under this practical expedient, the Company is allowed to recognize revenues, over time, in the amount to which the Company has a right to invoice. In addition, the Company is not required to estimate such variable consideration upon inception of the contract or reassess the estimate each reporting period. The Company determined that this method best represents the transfer of services as, upon billing, the Company has a right to consideration from a customer in an amount that directly corresponds with the value to the customer of the Company’s performance completed to date.
The Company accounts for individual goods and services separately if they are distinct performance obligations, which often requires significant judgment based upon knowledge of the products and/or services, the solution provided and the structure of the sales contract. In SaaS agreements, we provide a service to the customer that combines the software functionality, maintenance and hosting into a single performance obligation. In product-related contracts, a purchase order may cover different products, each constituting a separate performance obligation.
We generally estimate variable consideration at the most likely amount to which we expect to be entitled and in certain cases based on the expected value, which requires judgment. We include estimated amounts in the transaction price to the extent it is probable that a significant reversal of cumulative revenues recognized will not occur when the uncertainty associated with the variable consideration is resolved. Our estimates of variable consideration and determination of whether to include estimated amounts in the transaction price are based largely on an assessment of our anticipated performance and all information (historical, current and forecasted) that is reasonably available to us. We review and update these estimates on a quarterly basis.



6

The Company’s typical performance obligations include the following:
Performance Obligation
When Performance
Obligation is Typically
Satisfied
When Payment is
Typically Due
How Standalone
Selling Price is
Typically Estimated
Product Revenues
Standard purchase orders for delivery of a tangible product
Upon shipment (point in time)
Within 30 days of delivery
Observable transactions
Engineering services where the deliverable is considered a product
As work is performed (over time)
Within 30 days of services being invoiced
Estimated using a cost-plus margin approach
Service Revenues
Engineering, managed services, and consulting services
As work is performed (over time)
Within 30 days of services being invoiced
Estimated using a cost-plus margin approach
SaaS
Over the course of the SaaS service once the system is available for use (over time)
At the beginning of the contract period
Estimated using a cost-plus margin approach
Extended warranty serviceOver the course of the extended warranty period (over time)
At the beginning of the contract period
Estimated using a cost-plus margin approach
Disaggregation of Revenues
The Company disaggregates revenues from contracts with customers into product revenues and service revenues.
Trade Accounts Receivable and Contract Balances
We classify our right to consideration in exchange for goods and services as either a receivable or a contract asset. A receivable is a right to consideration that is unconditional (i.e., only the passage of time is required before payment is due). We present such receivables in trade accounts receivable, net in the accompanying balance sheet at their net estimated realizable value.
The Company maintains an allowance for credit losses to provide for the estimated amount of receivables that will not be collected. The Company estimates allowances for expected credit losses on trade accounts receivable and contract assets as required by the Current Expected Credit Loss (“CECL”) model pursuant to Accounting Standards Codification ("ASC") 326 - Financial Instruments - Credit Losses. If warranted, the allowance is increased by the Company’s provision for doubtful accounts, which is charged against income. All recoveries on receivables previously charged off are included in income, while direct charge-offs of receivables are deducted from the allowance.
A contract asset is a right to consideration that is conditional upon factors other than the passage of time. Contract assets are presented as unbilled accounts receivable in the accompanying balance sheet. For example, we would record a contract asset if we record revenues on a professional services engagement, but are not entitled to bill until we achieve specified milestones.
Our contract assets and refund liabilities are reported in a net position on a contract basis at the end of each reporting period. Refund liabilities are consideration received in advance of the satisfaction of performance obligations.
Contract Fulfillment Costs
The Company evaluates whether to capitalize the costs of fulfilling a contract. Such costs would be capitalized when they are not within the scope of other standards and: (1) are directly related to a contract; (2) generate or enhance resources that will be used to satisfy performance obligations; and (3) are expected to be recovered. There were approximately $0.4 million and $0.5 million of contract fulfillment costs as of June 30, 2024 and March 31, 2024, respectively, which are presented in the accompanying unaudited condensed balance sheets as prepaid expense. These costs primarily relate to the satisfaction of performance obligations related to the set-up of SaaS platforms. These costs are amortized on a straight-line basis over the estimated useful life of the SaaS platform.
7

Transaction Price Allocated to the Remaining Performance Obligations
As of June 30, 2024 and March 31, 2024, the aggregate amount of transaction price allocated to remaining performance obligations was immaterial, primarily as a result of the termination provisions within our contracts, which make the duration of the accounting term of the contract one year or less.
Practical Expedients and Exemptions
T&M and CPFF contracts are considered variable consideration. However, performance obligations with an underlying fee type of T&M or CPFF qualify for the “Right to Invoice” Practical Expedient under ASC 606-10-55-18. Under this practical expedient, the Company is not required to estimate such variable consideration upon inception of the contract or reassess the estimate each reporting period.
The Company utilizes the practical expedient under ASC 606-10-50-14 of not disclosing information about its remaining performance obligations for contracts with an original expected duration (i.e., contract term, determined based on the analysis of termination provisions described above) of 12 months or less.
The Company pays sales commissions on certain sales contracts. These costs are accrued in the same period that the revenues are recorded. Using the practical expedient under ASC 340-40-25-4, the Company recognizes the incremental costs of obtaining a contract as an expense when incurred since the amortization period of the asset that the Company otherwise would have recognized is one year or less.
The Company utilizes the practical expedient under ASC 606-10-25-18B to account for shipping and handling as fulfillment costs, and not a promised service (a revenue element). Shipping and handling costs are included as cost of revenues in the period during which the products ship.
The Company excludes from the transaction price all sales taxes that are assessed by a governmental authority and that are imposed on and concurrent with a specific revenue-producing transaction and collected from a customer (for example, sales, use, value added, and some excise taxes). This employs the practical expedient under ASC 606-10-32-2A. Sales taxes are presented on a net basis (excluded from revenues) in the accompanying statements of income.
Deferred Revenues
Deferred revenue in the accompanying unaudited condensed balance sheets is composed of consideration received in advance of the satisfaction of performance obligations. Deferred revenue that is not expected to be recognized within the next twelve months is included in other long-term liabilities on the accompanying unaudited condensed balance sheets and was $4.0 million and $3.4 million as of June 30, 2024 and March 31, 2024, respectively.
Concentration of Credit Risk
Financial instruments that potentially subject us to a concentration of credit risk consist principally of cash and cash equivalents and trade accounts receivable.
Cash and cash equivalents consist primarily of demand deposits and money market funds maintained with two financial institutions. Deposits held with banks may exceed the amount of insurance provided on such deposits. Generally, these deposits may be redeemed upon demand and are maintained with high quality financial institutions, and therefore are believed to have minimal credit risk. Accounts at each institution are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000. As of June 30, 2024, the Company had approximately $21.1 million of deposits at financial institutions in excess of the FDIC insured limit.
Our accounts receivable are primarily derived from billings with customers located throughout North America. We generally do not require collateral or other security from our North American customers. We maintain an allowance for credit losses, which losses have historically been within management’s expectations.
We currently have, and historically have had, a diverse customer base. For the three months ended June 30, 2024 and 2023, no individual customer represented greater than 10% of our total revenues. As of June 30, 2024 and March 31, 2024, no individual customer represented greater than 10% of our total accounts receivable.
8

Fair Values of Financial Instruments
The accounting guidance provided in ASC 820, Fair Value Measurement for fair value provides a framework for measuring fair value, clarifies the definition of fair value, and expands disclosures regarding fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the reporting date. The accounting guidance establishes a three-tiered hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value as follows:
Level 1—Unadjusted quoted prices in active markets for identical assets or liabilities accessible to the reporting entity at the measurement date.
Level 2—Observable inputs other than quoted prices in active markets for identical assets or liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
Level 3—Inputs that are generally unobservable and typically reflect management's estimate of assumptions that market participants would use in pricing the assets or liabilities.
The Company applies fair value accounting for all financial instruments on a recurring basis. The Company's financial instruments, which include cash, cash equivalents, accounts receivable and accounts payable are recorded at their carrying amounts, which approximate their fair values due to their short-term nature. All marketable securities are considered to be available-for-sale and recorded at their estimated fair values. In valuing these items, the Company uses inputs and assumptions that market participants would use to determine their fair value, utilizing valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs.
Cash, Cash Equivalents and Restricted Cash
Cash and cash equivalents consist of cash and short-term investments with initial maturities of 90 days or less.
As of June 30, 2024 and March 31, 2024, restricted cash was $0.2 million and $0.1 million, respectively, consisting of cash restricted for share purchases under the Employee Stock Purchase Plan (“ESPP”) (see Note 7, Stock-Based Compensation, for further details on the ESPP).
Cash, cash equivalents and restricted cash presented in the accompanying unaudited condensed statements of cash flows consisted of the following:
June 30,
20242023
(In thousands)
Cash and cash equivalents$21,377 $19,994 
Restricted cash248 274 
$21,625 $20,268 
Allowance for Credit Loss
We record accounts receivable net of the allowance for credit losses. The allowance is established in accordance with the CECL model. We estimate the allowance for credit losses based on the Company’s assessment of its ability to collect on customer accounts receivable. The collectability of our accounts receivable is evaluated through review of outstanding invoices and ongoing credit evaluations of our customers’ financial condition. In cases where we are aware of circumstances that may impair a specific customer’s ability to meet its financial obligations subsequent to the original sale, we will record an allowance against amounts due, and thereby reduce the net recognized accounts receivable to the amount we reasonably believe will be collected. The allowance reflects our best estimate of probable losses associated with the accounts receivable balance. Our assessment is based on historical experience, current information and reasonable and supportable forecasts. Accounts receivables with similar risk characteristics are evaluated collectively and accounts receivables that do not share similar risk characteristics are evaluated individually. Risk characteristics relevant to the Company’s accounts receivable include account balance and aging status. Adjustments to the allowance for credit losses are recorded through bad debt expense, which is included in operating expenses on the accompanying statements of income. The Company writes off accounts receivable against the allowance when it determines that the balance is uncollectible and collection of the receivable is no longer being actively pursued.
9

Inventories
Inventories consist of raw materials, work-in-process, and finished goods and are stated at the lower of cost or net realizable value. Cost is determined using the first-in, first-out method.
Property and Equipment
Property and equipment are recorded at cost and are depreciated using the straight-line method over the estimated useful life ranging from two to eight years. Leasehold improvements are depreciated over the term of the related lease or the estimated useful life of the improvement, whichever is shorter.
Intangible Assets
Intangible assets with determinable economic lives are carried at cost, less accumulated amortization. Amortization is computed over the estimated useful life of each asset on a straight-line basis. The Company determines the useful lives of identifiable intangible assets after considering the specific facts and circumstances related to each intangible asset. When determining useful life, the Company considers the contractual term of any agreement related to the asset, the historical performance of the asset, the Company's long-term strategy for using the asset, any laws or other local regulations which could impact the useful life of the asset and other economic factors, including competition and specific market conditions. We carry intangible assets without determinable economic lives at cost, and do not amortize them. We review such intangible assets for impairment at least annually.
Capitalized Software Development Cost
The Company accounts for costs incurred to develop software for internal use in accordance with ASC 350-40, Intangibles — Internal Use Software (“ASC 350-40”). Under ASC 350-40, the costs incurred during the application development stage, which include costs of software configuration and interface design, coding, installation and testing are required to be capitalized. Costs incurred during the preliminary project design along with post-implementation stages of internal use software are expensed as incurred and included in research and development in the statements of income.
Goodwill
Goodwill represents the excess of the purchase price over the fair value of net assets acquired in a business combination. We test goodwill for impairment in accordance with the provisions of ASC 350, Intangibles – Goodwill and Other, (“ASC 350”). Goodwill is tested for impairment at least annually at the reporting unit level or whenever events or changes in circumstances indicate that goodwill might be impaired. ASC 350 provides that an entity has the option to first assess qualitative factors to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the fair value of a reporting unit is less than its carrying amount.
The events and circumstances we consider in performing the qualitative assessment include macroeconomic conditions, industry and market considerations, overall financial performance of the reporting units and other relevant entity-specific events. If, after assessing the totality of events or circumstances, an entity determines that it is more likely than not that the fair value of a reporting unit is equal to or exceeds its carrying value, then additional impairment testing is not required. However, if an entity concludes otherwise, then it is required to perform an impairment test, which involves comparing the estimated fair value of a reporting unit with its book value, including goodwill. To estimate the fair value of the reporting unit for the impairment test, the entity can use an income approach, a market approach, or a combination of both. If the estimated fair value exceeds book value, goodwill is not considered to be impaired. If, however, the estimated fair value of a reporting unit is less than its book value, then we recognize an impairment loss equal to the amount that the book value of the reporting unit exceeds its estimated fair value, not to exceed the total amount of goodwill allocated to the reporting unit.
We monitor the indicators for goodwill impairment between annual tests. During the three months ended June 30, 2024 and 2023, we did not recognize an impairment loss for goodwill.
Impairment of Long-Lived Assets
The Company evaluates its long-lived assets, including property, equipment and intangible assets (other than goodwill) for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset might not be recoverable. We determine whether the carrying value of an asset or asset group is recoverable, based on comparisons to undiscounted expected future cash flows we expect the asset or asset group to generate. If an asset is not recoverable, we record an impairment loss equal to the amount by which the carrying value of the asset exceeds its fair value. During the three months ended June 30, 2024 and 2023, we did not recognize an impairment loss to our long-lived and intangible assets.
10

Income Taxes
We utilize the asset and liability method of accounting for income taxes, under which deferred taxes are determined based on the temporary differences between the financial statement and tax basis of assets and liabilities using tax rates expected to be in effect during the years in which the basis differences reverse. A valuation allowance is recorded when it is more-likely-than-not that some or all of the deferred tax assets will not be realized, which increases our income tax expense in the period such determination is made. As such, as of June 30, 2024, we determined it was appropriate to record a full valuation allowance against our deferred tax assets. We will continuously reassess the appropriateness of maintaining a valuation allowance. We intend to continue maintaining a full valuations allowance on our deferred tax assets until there is sufficient evidence to support the reversal of all or some portion of these allowances. However, given our current earnings and anticipated future earnings, we believe that there is a reasonable possibility that within the next twelve months, sufficient positive evidence may become available to allow us to reach a conclusion that a significant portion of the valuation allowance will no longer be needed. Release of the valuation allowance would result in the recognition of certain deferred tax assets and a decrease to income tax expense for the period the release is recorded. However, the exact timing and amount of the valuation allowance release are subject to change on the basis of the level of profitability that we are able to actually achieve.
Income tax positions must meet a more-likely-than-not recognition threshold to be recognized. Income tax positions that previously failed to meet the more-likely-than-not threshold are recognized in the first subsequent financial reporting period in which that threshold is met. Previously recognized tax positions that no longer meet the more-likely-than-not threshold are derecognized in the first subsequent financial reporting period in which that threshold is no longer met.
Stock-Based Compensation
We record stock-based compensation in our unaudited condensed statements of income as an expense, based on the estimated grant date fair value of our stock-based awards, whereby such fair values are amortized over the requisite service period. Our stock-based awards currently comprise common stock options, restricted stock units and performance stock units. The fair value of our common stock option awards is estimated on the grant date using the Black-Scholes-Merton option-pricing formula. The fair value of our performance stock unit awards is estimated on the grant date using a Monte Carlo simulation model. While the use of these models meets established requirements, the estimated fair values generated by the models might not be indicative of the actual fair values of our awards as it does not consider certain factors important to those awards to employees, such as continued employment and periodic vesting requirements, as well as limited transferability. The fair value of our restricted stock units is based on the closing market price of our common stock on the grant date. If there are any modifications or cancellations of the underlying unvested stock-based awards, we may be required to accelerate, increase or cancel any remaining unearned stock-based compensation expense.
Research and Development Expenditures
We expense research and development expenditures in the period incurred.
Shipping and Handling Costs
We include shipping and handling costs in the cost of revenues in the period during which the products ship.
Sales Taxes
We present sales taxes on a net basis (excluded from revenues) in the statements of income.
Right-of-Use Assets and Lease Liabilities
We determine if an arrangement contains a lease at inception and classify the lease as either an operating or finance lease at its commencement.
Right-of-use assets and lease liabilities are recorded based on the present value of future lease payments, which factors in certain qualifying initial direct costs incurred as well as any lease incentives received. If an implicit rate is not readily determinable, we utilize inputs from third-party lenders to determine the appropriate discount rate. Lease expense for operating lease payments is recognized on a straight-line basis over the lease term. Finance leases incur interest expense using the effective interest method in addition to amortization of the leased asset on straight-line basis, both over the applicable lease term. Lease terms may factor in options to extend or terminate the lease.
11

We adhere to the short-term lease recognition exemption for all classes of assets (i.e., facilities and equipment). As a result, leases with an initial term of twelve months or less are not recorded on the balance sheet and are recognized on a straight-line basis over the lease term. In addition, for certain equipment leases, we account for lease and non-lease components, such as services, as a single lease component as permitted.
Warranty
We generally provide a two- to three-year warranty on materials and workmanship from the original invoice date on all products manufactured by the Company. Products sold to various original equipment manufacturer customers sometimes carry longer warranties. We will either repair or replace defective products, usually at our option, upon meeting certain criteria. We accrue a provision for the estimated costs that may be incurred for product warranties relating to a product as a component of cost of sales at the time revenues for that product is recognized. The accrued warranty reserve is included within accrued liabilities in the accompanying unaudited condensed balance sheets. We do not provide any service-type warranties.
Repair and Maintenance Costs
We incur repair and maintenance costs in the normal course of business. Should the repair or maintenance result in a permanent improvement to one of our leased facilities, the cost is capitalized as a leasehold improvement and amortized over its useful life or the remainder of the lease period, whichever is shorter. Non-permanent repair and maintenance costs are expensed as incurred.
Loss Contingencies
We are subject to legal actions that arise in the ordinary course of business. The Company recognizes a liability for a contingency when it is probable that liability has been incurred and when the amount of loss can be reasonably estimated. When a range of probable loss can be estimated, the Company accrues the most likely amount of such loss at no less than the minimum of the range. The Company expenses legal defense costs as incurred.
Comprehensive Income
Net income was the same as comprehensive income for the three months ended June 30, 2024 and 2023.
Recent Accounting Pronouncements
In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280), which is intended to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant expenses. This ASU is applicable to our Annual Report on Form 10-K for the fiscal year ending March 31, 2025, and subsequent interim periods. Early adoption is permitted and the amendments in this ASU should be applied retroactively. We are currently evaluating the impact of this ASU on our financial statement disclosures.
In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740), which includes amendments that further enhance income tax disclosures, primarily through standardization and disaggregation of rate reconciliation categories and income taxes paid by jurisdictions. This ASU is applicable to our Annual Report on Form 10-K for the fiscal year ending March 31, 2026. Early adoption is permitted and the amendments in this ASU should be applied prospectively. Retrospective application is permitted. We are currently evaluating the impact of this ASU on our financial statement disclosures.
12

2.Supplemental Financial Information
Inventories
The following table presents details of our inventories, net:
June 30,
2024
March 31,
2024
(In thousands)
Raw materials$11,514 $9,063 
Work in process185 468 
Finished goods3,142 3,901 
$14,841 $13,432 
Property and Equipment
The following table presents details of our property and equipment, net:
June 30,
2024
March 31,
2024
(In thousands)
Equipment$6,968 $6,871 
Leasehold improvements858 828 
Accumulated depreciation(6,538)(6,403)
$1,288 $1,296 
Depreciation expense was approximately $0.1 million and $0.2 million for the three-month periods ending June 30, 2024 and June 30, 2023, respectively. Depreciation expense is included in cost of revenues and operating expenses in our unaudited condensed statements of income.
Intangible Assets
The following table presents details of our net intangible assets:
June 30, 2024March 31, 2024
Gross
Carrying
Amount
Accumulated
Amortization
Net Book
Value
Gross
Carrying
Amount
Accumulated
Amortization
Net Book
Value
(In thousands)
Technology$5,029 $(4,601)$428 $5,009 $(4,369)$640 
Customer contracts / relationships9,550 (6,136)3,414 9,550 (5,783)3,766 
Trade names and non-compete agreements782 (770)12 782 (770)12 
Capitalized software development costs10,315 (5,378)4,937 10,164 (4,980)5,184 
Total$25,676 $(16,885)$8,791 $25,505 $(15,902)$9,602 
Amortization expense for intangible assets subject to amortization was approximately $1.0 million and $0.8 million for the three-month periods ended June 30, 2024 and 2023, respectively. Of the total amortization expense, approximately $0.3 million and $0.1 million was recorded to cost of revenues for each of the three-month periods ended June 30, 2024 and 2023, respectively, and approximately $0.7 million was recorded to operating expenses for each of these three-month periods.
We have one indefinite useful life intangible asset, with de minimis carrying value, which was included in trade names and non-compete agreements.
13

As of June 30, 2024, future estimated amortization expense was as follows:
Year Ending March 31,
(In thousands)
2025$2,586 
20262,359 
20272,036 
20281,295 
2029503 
$8,779 
The future estimated amortization expense does not include the indefinite useful life intangible asset described above.
Goodwill
Goodwill was $28.3 million as of June 30, 2024 and March 31, 2024. There was no change to the goodwill carrying value during the three-month period ending June 30, 2024.
Warranty Reserve Activity
Warranty reserve is recorded as accrued liabilities in the accompanying unaudited condensed balance sheets. The following table presents activity related to the warranty reserve:
Three Months Ended
June 30,
20242023
(In thousands)
Balance at beginning of fiscal year$813 $758 
Additions charged to cost of sales48 193 
Warranty claims(5)(96)
Balance at end of reporting period$856 $855 
Earnings Per Share
The following table sets forth the computation of basic and diluted net income per share:
Three Months Ended
June 30,
20242023
(In thousands, except per share amounts)
Numerator:
Net income$392 $2,125 
Denominator:
Weighted average common shares used in basic computation42,969 42,567 
Stock options and other dilutive awards1,001 1,073 
Weighted average common shares used in diluted computation43,970 43,640 
Net income per common share
     Basic net income per share $0.01 $0.05 
     Diluted net income per share $0.01 $0.05 
14

The following instruments were excluded for purposes of calculating weighted average common share equivalents in the computation of diluted net income per share as their effect would have been anti-dilutive:
Three Months Ended
June 30,
20242023
(In thousands)
Stock options3,677 3,362 
Restricted stock units18 280 
3.Fair Value Measurements
We measure fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. As described in more detail in Note 1, Description of Business and Summary of Significant Accounting Policies, fair value measurements are based on a three-tier hierarchy that prioritizes the inputs used to measure fair value.
We did not have any material financial assets or liabilities measured at fair value on a recurring basis using Level 3 inputs as of June 30, 2024 or March 31, 2024. Our non-financial assets, such as goodwill, intangible assets and property and equipment, are measured at fair value on a nonrecurring basis, generally when there is a transaction involving those assets such as a purchase transaction, a business combination or an adjustment for impairment. No non-financial assets were measured at fair value at June 30, 2024 and March 31, 2024.
The following tables present the Company’s financial assets and liabilities that are recorded at fair value on a recurring basis, segregated among the appropriate levels within the fair value hierarchy:
As of June 30, 2024
Amortized
Cost
Gross
Unrealized
Loss
Gross
Unrealized
Gain
Estimated Fair
Value
(In thousands)
Assets:
Level 1:
Securities held in deferred compensation plan (1)
$1,461 $(681)$843 $1,623 
Liabilities:
Level 1:
Deferred compensation plan liabilities (2)
$1,474 $(535)$702 $1,641 

15

As of March 31, 2024
Amortized
Cost
Gross
Unrealized
Loss
Gross
Unrealized
Gain
Estimated Fair
Value
(In thousands)
Assets:
Level 1:
Securities held in deferred compensation plan (1)
$1,539 $(542)$650 $1,647 
Liabilities:
Level 1:
Deferred compensation plan liabilities (2)
$1,415 $(485)$633 $1,563 
(1) Included in prepaid expenses and other current assets on the Company’s balance sheets.
(2) Included in accrued payroll and related expenses on the Company’s balance sheets.
Unrealized losses related to investments are due to interest rate fluctuations as opposed to credit quality. In addition, we do not intend to sell, nor is it more likely than not that we would be required to sell, any of our investments before recovery of their cost basis. As a result, there was no other-than-temporary impairment for these investments as of June 30, 2024.
4.Income Taxes
The effective tax rate used for interim periods is the estimated annual effective tax rate, based on the current estimate of full year results, not including taxes related to specific events. Taxes relate to specific events, if any, are recorded in the interim period in which they occur.
Income tax expense for the three months ended June 30, 2024 was less than $0.1 million, or 10.9% of the pretax income, as compared with an expense of approximately $0.1 million, or 4.3% of pretax income, for the three months ended June 30, 2023.
In assessing the realizability of our deferred tax assets, we review all available positive and negative evidence, including reversal of deferred tax liabilities, potential carrybacks, projected future taxable income, tax planning strategies and recent financial performance. As the Company has sustained a cumulative pre-tax loss over the trailing three years, we consider it appropriate to maintain a valuation allowance on our deferred tax assets. We recorded a valuation allowance against all of our deferred tax assets as of June 30, 2024, and March 31, 2024. We intend to continue maintaining a full valuation allowance on our deferred tax assets until there is sufficient evidence to support the reversal of all or some portion of these allowances. However, given our current earnings and anticipated future earnings, we believe that there is a reasonable possibility that within the next twelve months, sufficient positive evidence may become available to allow us to reach a conclusion that a significant portion of the valuation allowance will no longer be needed. Release of the valuation allowance would result in the recognition of certain deferred tax assets and a decrease to income tax expense for the period the release is recorded. However, the exact timing and amount of the valuation allowance release are subject to change on the basis of the level of profitability that we are able to actually achieve.
16

5.Commitments and Contingencies
Litigation and Other Contingencies
As a provider of traffic engineering services, hardware products, software and other various solutions for the traffic industry, the Company is, and may in the future from time to time, be involved in disputes, proceedings, or litigation relating to claims arising out of its operations in the normal course of business, such as intellectual property infringement and contractual matters. While the Company cannot accurately predict the outcome of any such disputes, proceedings, or litigation, the Company is not a party to any legal dispute, proceeding, or litigation, the outcome of which, in management’s opinion, individually or in the aggregate, would have a material adverse effect on the Company’s business, results of operations, financial position or cash flows.
The Company agreed to accept a $1.0 million return of inventory sold by the Company during the three months ended June 30, 2023, at the request of a prime contractor and related to a project that has been delayed and for which there were no known issues with the product. The Company was a subcontractor to the prime contractor on the delayed project. Up to mid-July 2023 the Company believed the probability of the occurrence of a loss associated with this matter was remote. After meeting with the prime contractor beginning in mid-July 2023, the Company agreed to reassess the situation and agreed on August 7, 2023, to accept the inventory return. For the three months ended June 30, 2023, we recognized a pretax loss contingency of $0.2 million, $1.0 million in accrued liabilities representing the sale value of the inventory and $0.8 million in prepaid expenses and other current assets representing the estimated value of the inventory to be returned in the future. The inventory was returned, and the accrued liability was paid. As of June 30, 2024 and March 31, 2024, there were no outstanding contingencies related to this inventory.
6.Right-of-Use Assets and Lease Liabilities
We have various operating leases for our offices, office equipment and vehicles in the United States. These leases expire at various times through 2030. Certain lease agreements contain renewal options from 1 year to 5 years, rent abatement, and escalation clauses that are factored into our determination of lease payments when appropriate.
The table below presents lease-related assets and liabilities recorded on the unaudited condensed balance sheet as follows:
ClassificationJune 30, 2024March 31, 2024
(In thousands)
Assets
Operating lease right-of-use-assetsRight-of-use assets$6,827 $7,237 
Total operating lease right-of-use-assets$6,827 $7,237 
Liabilities
Operating lease liabilities (short-term)Accrued liabilities$2,176 $2,233 
Operating lease liabilities (long-term)Lease liabilities5,857 6,210 
Total lease liabilities$8,033 $8,443 

Lease Costs
We recorded approximately $0.6 million of lease costs in our unaudited condensed statements of income for each of the three months ended June 30, 2024 and 2023.
17

Supplemental Information
Information related to the Company right-of-use assets and related operating lease liabilities were as follows:
Three Months Ended
June 30,
(Dollars in thousands)
20242023
Cash paid for amounts included in the measurement of operating lease liabilities $815$673
Weighted average remaining lease term (in years)3.523.90
Weighted average discount rate5.0 %4.7 %
Undiscounted Cash Flows
The table below reconciles the undiscounted cash flows for each of the next five years and the total of the remaining years to the operating lease liabilities recorded on the balance sheet as of June 30, 2024:
Fiscal Year Ending March 31,Operating Leases
(In thousands)
2025$1,931 
20262,436 
20262,498 
20281,447 
2029293 
Thereafter188 
Total lease payments8,793 
Less imputed interest(760)
Present value of future lease payments8,033 
Less current obligations under leases(2,176)
Long-term lease obligations$5,857 

18

7.Stock-Based Compensation
We currently maintain two stock incentive plans, the 2007 Omnibus Incentive Plan and the 2016 Omnibus Incentive Plan (the “2016 Plan”). Of these plans, we may only grant future awards from the 2016 Plan. The 2016 Plan allows for the issuance of stock options, stock appreciation rights, restricted stock, time-restricted stock units (“RSUs”), performance-based restricted stock units (“PSUs”), cash incentive awards and other stock-based awards. At June 30, 2024, there were approximately 1.1 million shares of common stock available for grant or issuance under the 2016 Plan. Total stock options vested and expected to vest were approximately 6.2 million as of June 30, 2024.
Stock Options
A summary of activity with respect to our stock options for the three months ended June 30, 2024 is as follows:
SharesWeighted-
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Life
Aggregate
Intrinsic
Value
(In thousands)(Years)(In thousands)
Options outstanding at March 31, 20245,858 $4.11 
Granted369 4.21 
Exercised(3)3.47 
Forfeited(67)4.02 
Expired(3)4.79 
Options outstanding at June 30, 20246,154 4.12 5.4$3,484 
Options vested and exercisable at June 30, 20244,267 4.15 4.0$2,647 
Restricted Stock Units
A summary of activity with respect to our RSUs, which entitle the holder to receive one share of our common stock for each RSU upon vesting, for the three months ended June 30, 2024 is as follows:
SharesWeighted-Average
Grant Date
Fair Value
(In thousands)
RSUs outstanding at March 31, 2024793 $4.18 
Granted110 4.27 
Vested and released  
Forfeited(24)3.49 
RSUs outstanding at June 30, 2024879 4.21 
Performance Stock Units
The Company approves a “target” number of PSUs for our executive officers with performance and service-based vesting conditions. The actual number of units that ultimately vest will range from 0% to 200% of the original units awarded based on level of achievement. Between 0% and 160% of the PSUs will be eligible to vest based on annual performance during the three-year performance period relative to the revenues per share and cash flow from operations objectives to be established by the Compensation Committee at the beginning of each fiscal year. In addition, the final PSU vesting based on the revenues per share and cash flow from operations performance will be subject to a modifier between 0.75x and 1.25x based on the Company's total shareholder return relative to the Russell 2000 during the performance period, for a maximum achievement percentage of 200% of the "target" number of PSUs. The PSUs are amortized over a service period of three years. We estimated the value and the derived service period of the PSUs using the Monte Carlo simulation model.
19

In accordance with ASC 718 - Compensation – Stock Compensation, grant date is the date at which the grantor and the grantee reach a mutual understanding of the key terms and conditions of a share-based payment award. For PSU awards with performance conditions to be established by the Compensation Committee at a future date, the grant date does not occur until the vesting conditions are established and communicated to the employees.
The following table summarizes the details of the performance stock units:
SharesWeighted-Average
Grant Date
Fair Value
(In thousands)
PSUs outstanding at March 31, 2024117 $4.75 
Granted83 4.55 
Vested and released(31)5.02 
Forfeited(14)6.16 
PSUs outstanding at June 30, 2024155 4.43 
Stock-Based Compensation Expense
The following table presents stock-based compensation expense that is included in each line item on our unaudited condensed statements of income:
Three Months Ended
June 30,
20242023
(In thousands)
Cost of revenues$89 $85 
General and administrative361 202 
Sales and marketing55 134 
Research and development90 104 
Total stock-based compensation$595 $525 
As of June 30, 2024, there was approximately $3.3 million, $1.8 million and $0.5 million of unrecognized compensation expense related to unvested stock options, RSUs and PSUs, respectively. This expense is currently expected to be recognized over a weighted average period of approximately 2.6 years for stock options, 1.7 years for RSUs and 2.1 years for PSUs. If there are any modifications or cancellations of the underlying unvested awards, we may be required to accelerate, increase or cancel any remaining unearned stock-based compensation expense. Future stock-based compensation expense and unearned stock-based compensation will increase to the extent that we grant additional stock options, RSUs or other stock-based awards.
Other Stock-Based Compensation Plans
We currently maintain an Employee Stock Purchase Plan that allows employees to have a percentage of their base compensation withheld to purchase the Company’s common stock at 95% of the lower of the fair market price at the beginning of the offering period or on the last trading day of the offering period. There are two offering periods during a calendar year, which consist of the six months beginning each January 1 and July 1. Employees may contribute 1-15% of their eligible gross pay up to a $0.03 million annual stock value limit. No shares were purchased during the three months ended June 30, 2024 and June 30, 2023 for the first offerings periods of Fiscal 2025 and 2024.
20

Deferred Compensation Plan
Effective October 1, 2020, the Company adopted the Iteris, Inc. Deferred Compensation Plan (the “DC Plan”). The DC Plan consists of two plans, one that is intended to be an unfunded arrangement for eligible employees who are part of a select group of management or highly compensated employees of the Company within the meaning of Sections 201(2), 301(a)(3) and 401(a)(1) of ERISA, and one for the benefit of non-employee members of our board of directors. Key employees, including our executive officers, and our non-employee directors who are notified regarding their eligibility to participate and delivered the DC Plan enrollment materials are eligible to participate in the DC Plan. Under the DC Plan, we provide participants with the opportunity to make annual elections to defer a percentage of their eligible cash compensation and equity awards. A participant is always 100% vested in his or her own elective cash deferrals and any earnings thereon. Elective deferrals of equity awards are credited to a bookkeeping account established in the name of the participant with respect to an equivalent number of shares of our common stock, and such credited shares are subject to the same vesting conditions as are applicable to the equity award subject to the election. The Company established a rabbi trust to finance our obligations under the DC Plan with corporate-owned life insurance policies on participants, and the assets held within this trust are subject to the claims of the Company's creditors. The assets and liabilities are recorded at their fair value, which represents their respective amortized cost values plus any unrealized gains or losses. Refer to Note 3, Fair Value Measurements, for further detail on the DC Plan.
8.Stock Repurchase Program
On May 12, 2022, the Board of Directors approved a new plan for the Company to acquire up to $10.0 million of its outstanding common stock for an unspecified length of time (the "2022 Stock Repurchase Program"). Under the 2022 Stock Repurchase Program, we may repurchase shares from time to time in the open market and in privately negotiated transactions and block trades and may also repurchase shares pursuant to a 10b5-1 trading plan during our closed trading windows. There is no guarantee as to the exact number of shares that will be repurchased. We may modify or terminate the 2022 Stock Repurchase Program at any time without prior notice.
During the quarter ended June 30, 2024, we repurchased 146,541 shares for an aggregate price of approximately $0.6 million at an average price of $4.24 per share. From the inception of the 2022 Stock Repurchase Program through June 30, 2024, we repurchased approximately 486,402 shares of our common stock for an aggregate price of approximately $1.7 million, at an average price per share of $3.47. As of June 30, 2024, 339,861 repurchased shares have been retired and resumed their status as authorized and unissued shares of our common stock. As of the quarter ended June 30, 2024, approximately $8.3 million remained available for the repurchase of our common stock under our 2022 Stock Repurchase Program.
9.Business Segments
The Company's Chief Operating Decision Maker (“CODM”), who is our Chief Executive Officer, reviews the Company's results on a consolidated basis and our financial results are presented under a single reportable segment to provide the most accurate representation of the Company's performance.

21

ITEM 2.  MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Forward-Looking Statements
This report, including the following discussion and analysis, contains forward-looking statements (within the meaning of the Private Securities Litigation Reform Act of 1995) that are based on our current expectations, estimates and projections about our business and our industry, and reflect management’s beliefs and certain assumptions made by us based upon information available to us as of the date of this report. When used in this report and the information incorporated herein by reference, the words “expect,” “believe,” “intend,” “plan,” “should,” “will,” “may,” "might," “anticipate,” “estimate,” “could,” “should,” and similar expressions or variations of these words are intended to identify forward-looking statements. These forward-looking statements include, but are not limited to, statements regarding our anticipated growth, sales, revenues, expenses, profitability, capital needs, backlog, manufacturing capabilities, the market acceptance of our products and services, competition, the impacts of any current or future litigation, the impacts of recent accounting pronouncements, the impacts of ongoing and new supply chain constraints, the status of our facilities and product development, reliance on key personnel, general economic conditions, including changing interest rates, the impacts of any future volatility or instability in national or international political conditions, any shutdown of the United Sates federal government, future impacts of COVID-19 and other future pandemics, and other characterizations of future events or circumstances are forward-looking statements. You should not place undue reliance on these forward-looking statements that speak only as of the date hereof. These statements are not guarantees of future performance and are subject to certain risks and uncertainties that could cause our actual results to differ materially and adversely from those projected. We encourage you to carefully read this report in conjunction with our annual report on Form 10-K in its entirety, including the various disclosures made by us which describe certain factors which could affect our business, such as those set forth in the “Risk Factors” of in Part II. Item 1A of this report, before deciding to invest in our Company or to maintain or increase your investment. We undertake no obligation to revise or update publicly any forward-looking statement for any reason, including to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
Overview
General
We are a provider of smart mobility infrastructure management solutions. Our cloud-enabled solutions help public transportation agencies, municipalities, commercial entities and other transportation infrastructure providers monitor, visualize, and optimize mobility infrastructure to make mobility safe, efficient, and sustainable for everyone.
Developments Impacting our Business
Climate Change
We take climate change and its associated risks seriously. Increased frequency of severe and extreme weather events associated with climate change could adversely impact our facilities, interfere with intersection construction projects, such as work stoppages and project delays or cancellations, and have a material impact on our financial condition, cash flows and results of operations. More extreme and volatile temperatures, increased storm intensity and flooding, and more volatile precipitation are among the weather events that are most likely to impact our business. We are unable to predict the timing or magnitude of these events. However, we perform ongoing assessments of physical risk, including physical climate risk, to our business and we continue to implement efforts to mitigate these physical risks on an ongoing basis.
As a global leader in smart mobility infrastructure management, we are committed to a cleaner, healthier and more sustainable future. Our core business aims to reduce climate impact through our work with public and private-sector partners to improve the efficiency of mobility, which, among other things, has the benefit of reducing carbon emissions. For example, by reducing vehicle delays and stops through traffic signal timing projects, improving the efficiency and fuel consumption of public transit via signal priority programs, and reducing time spent roadside for heavy-emitting commercial freight vehicles during inspection, our industry-leading portfolio of smart mobility infrastructure management solutions is currently helping cities and states to reduce their carbon footprint. Additionally, we continue to enhance the design of our sensors to withstand increasingly extreme weather conditions.
22


Non-GAAP Financial Measures
In addition to results presented in accordance with generally accepted accounting principles in the United States (“GAAP”), we have included the following non-GAAP financial measures: net income before interest, taxes, depreciation, amortization, stock-based compensation expense, executive severance and transition costs and other legal expenses (“Adjusted EBITDA”); and net income before depreciation, amortization, stock-based compensation expense, executive severance and transition costs, other legal expenses and the tax effect of adjustments (“Adjusted Net Income”). Basic and Diluted Adjusted Net Income Per Share (“Basic Adjusted EPS” and “Diluted Adjusted EPS”, collectively, “Adjusted EPS”) are calculated as Adjusted Net Income divided by our basic and diluted weighted-average number of shares outstanding, respectively. Components of these non-GAAP financial measures may be adjusted from time to time to reflect specific events and circumstances as they occur.
Adjusted EBITDA was $2.9 million for the three months ended June 30, 2024, as compared to approximately $4.0 million for the three months ended June 30, 2023.
Adjusted Net Income was $2.8 million for the three months ended June 30, 2024, as compared to approximately $4.0 million for the three months ended June 30, 2023.
When viewed with our financial results prepared in accordance with GAAP and accompanying reconciliations, we believe Adjusted EBITDA, Adjusted Net Income, Adjusted EPS and the related financial ratios provide additional useful information to clarify and enhance the understanding of the factors and trends affecting our past performance and future prospects. We define these measures, explain how they are calculated and provide reconciliations of these measures to the most comparable GAAP measure in the tables below. Adjusted EBITDA, Adjusted Net Income, Adjusted EPS and the related financial ratios, as presented in this Quarterly Report on Form 10-Q (“Form 10-Q”), are supplemental measures of our performance that are not required by or presented in accordance with GAAP. They are not a measurement of our financial performance under GAAP and should not be considered as alternatives to net income or any other performance measures derived in accordance with GAAP, or as an alternative to net cash provided by (used in) operating activities as measures of our liquidity. The presentation of these measures should not be interpreted to mean that our future results will be unaffected by unusual or nonrecurring items.
We use Adjusted EBITDA, Adjusted Net Income, Adjusted EPS and non-GAAP operating performance measures internally as complementary financial measures to evaluate the performance and trends of our businesses. We present Adjusted EBITDA, Adjusted Net Income, Adjusted EPS and the related financial ratios, as applicable, because we believe that measures such as these provide useful information with respect to our ability to meet our operating commitments.
Adjusted EBITDA, Adjusted Net Income, Adjusted EPS and the related financial ratios have limitations as analytical tools, and you should not consider them in isolation or as a substitute for analysis of our results as reported under GAAP. Some of these limitations include:
They generally do not reflect our cash expenditures, future requirements for capital expenditures or contractual commitments;
They do not reflect changes in, or cash requirements for, our working capital needs;
Although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and our non-GAAP measures do not reflect any cash requirements for such replacements;
They are not adjusted for all non-cash income or expense items that are reflected in our statements of cash flows;
They do not reflect the impact on earnings of charges resulting from matters unrelated to our ongoing operations; and
Other companies in our industry may calculate similarly-titled non-GAAP measures differently than we do, thereby limiting their usefulness as comparative measures.
23


Because of these limitations, Adjusted EBITDA, Adjusted Net Income, Adjusted EPS and the related financial ratios should not be considered as measures of discretionary cash available to us to invest in the growth of our business or as a measure of cash that will be available to us to meet our obligations. You should compensate for these limitations by relying primarily on our GAAP results and using Adjusted EBITDA, Adjusted Net Income, Adjusted EPS and the related financial ratios only as supplemental information. See our unaudited financial statements contained in this Form 10-Q. However, despite the above limitations, we believe that Adjusted EBITDA, Adjusted Net Income, Adjusted EPS and the related financial ratios are useful to an investor in evaluating our results of operations because these measures:
Are widely used by investors to measure a company’s operating performance without regard to items excluded from the calculation of such terms, which can vary substantially from company to company depending upon accounting methods and book value of assets, capital structure and the method by which assets were acquired, among other factors;
Help investors evaluate and compare the results of our operations from period to period by removing the effect of our capital structure from our operating performance; and
Are used by our management team for various other purposes including presentations to our Board of Directors as a basis for strategic planning and forecasting.
The following applicable financial items have been added back to or subtracted from our net income when calculating Adjusted EBITDA or Adjusted Net Income for the three months ended June 30, 2024 and 2023:
Income taxes. This amount may be useful to investors because it represents the taxes that might be payable for the period and the change in deferred taxes during the period, and therefore could reduce cash flow available for use in our business.
Depreciation expense. Iteris excludes depreciation expense primarily because it is a non-cash expense. This amount may be useful to investors because it generally represents the wear and tear on our property and equipment used in our operations.
Amortization expense. Iteris incurs amortization expense of intangible assets in connection with acquisitions. Iteris also incurs amortization expense related to capitalized software development costs. Iteris excludes these items because it does not believe that these expenses reflect our ongoing operating results in the period incurred. These amounts may be useful to investors because they represent the estimated attrition of our acquired customer base and the diminishing value of product rights.
Interest income and expense. Iteris excludes interest income and expense because it does not believe these items reflect our ongoing business and operating results. These amounts may be useful to investors for determining current cash flow. For the three months ended June 30, 2024, interest expense includes the higher cash balance held with banks and the interest rates associated with those accounts.
Stock-based compensation. These expenses consist primarily of expenses from employee and director equity-based compensation plans. Iteris excludes stock-based compensation primarily because it is a non-cash expense and Iteris believes that it is useful to investors to understand the impact of stock-based compensation to its results of operations and current cash flow.
Executive severance and transition costs. Iteris excludes executive severance and transition costs because it does not believe that these expenses are reflective of ongoing operating results in the period incurred. These amounts may be useful to our investors in evaluating our core operating performance.
24


Other legal expenses. Iteris excludes legal expenses that it believes are infrequent, unusual and not reflective of ongoing operating results in the period incurred. These amounts may be useful to our investors in evaluating our core operating performance. We do not adjust for any ordinary course legal expenses. For the three months ended June 30, 2024, other legal expenses consist of costs related to a specific breach of contract dispute for which the Company previously expected a settlement to be reached. However, due to a change in facts and circumstances that now point to a more protracted and costly process, we included the legal costs of $0.3 million incurred during the three months ended June 30, 2024 and $0.4 million for the three months ended June 30, 2023. The matter is currently scheduled to go to trial in September 2024, so related costs will likely increase in the near term. The Company believes that the probability of an outcome resulting in a loss is remote.
•    Tax effect of adjustments. This amount represents the income tax impact of the adjustments to net income, as the Company believes that its GAAP income tax benefit as reported is not representative of the income tax impact of the adjustments. The tax effect was determined by recalculating the Company’s current and deferred income tax expense after incorporating the non-GAAP adjustments listed on the Adjusted Net Income table. These amounts may be useful to our investors in evaluating our core operating performance.
The following tables present a reconciliation of historical net income to Adjusted EBITDA and the presentation of Adjusted EBITDA as a percentage of net revenues, and a reconciliation of historical net income to Adjusted Net Income and the presentation of Adjusted EPS.
Adjusted EBITDA
Three Months Ended
June 30,
20242023
(In thousands)
Net income$392$2,125
Provision for income taxes4895
Depreciation expense135150
Amortization expense982783
Interest income, net(131)(68)
Stock-based compensation595525
Other adjustments:
Executive severance and transition costs533
Other legal expenses346415
Adjusted EBITDA$2,900$4,025
Percentage of total revenues6.3 %9.2 %

25


Adjusted Net Income and Adjusted EPS
Three Months Ended
June 30,
20242023
(In thousands, except for share amounts)
Net income$392$2,125
Adjustments to net income:
Depreciation expense135150
Amortization expense982783
Stock-based compensation595525
Executive severance and transition costs533
Other legal expenses346415
Tax effect on adjustments(205)14
Adjusted Net Income$2,778$4,012
Adjusted Net Income per share:
Basic$0.06$0.09
Diluted$0.06$0.09
Weighted-average shares used in computing Adjusted Net Income per share:
Basic42,96942,567
Diluted43,97043,640


Three Months Ended
June 30,
20242023
Net income per share - basic$0.01$0.05
Adjusted Net Income adjustments(1)
0.050.04
Adjusted Net Income per share - basic$0.06$0.09
Three Months Ended
June 30,
20242023
Net income per share - diluted$0.01$0.05
Adjusted Net Income adjustments(1)
0.050.04
Adjusted Net Income per share - diluted$0.06$0.09
(1)Reflects the aggregate adjustments to net income made to calculate Adjusted Net Income, as presented in the above table, divided by the GAAP weighted-average number of shares outstanding for the relevant period, as presented above. Due to rounding, some amounts may not compute as shown.
Key Business Metrics
We define Annual Recurring Revenue (“ARR”) as revenues recognized under GAAP during a reporting period for our software-as-a-service (“SaaS”), data-as-a-service (“DaaS”), and managed services we provide to our customers. These services typically are secured through binding multi-year contracts or are subject to annual renewals. ARR is an important key performance metric we use in managing our business because it reflects a more predictable and stable component of our revenues, as well as a base from which we can expand our relationships with existing customers. Fluctuations in ARR can reflect a variety of factors including increases or decreases in multi-year contracts, as well as specific contract inception and termination dates because we do not annualize revenues included in ARR.
26


Backlog is an operational measure representing future unearned revenues amounts believed to be firm that are to be earned under our existing agreements, but it does not represent the total contract award if a firm commitment, purchase order or task order has not yet been issued under the contract and are not included in deferred revenues on our balance sheets. Backlog includes new bookings but does not include announced orders for which definitive contracts have not been executed. We typically expect to recognize revenues in the range of approximately two-thirds to three-quarters of our backlog as of the end of a fiscal year in the subsequent fiscal year. We believe backlog is a useful metric for investors, given its relevance to total orders, although there can be no assurances we will recognize revenues from bookings or backlog timely.
Critical Accounting Policies and Estimates
“Management’s Discussion and Analysis of Financial Condition and Results of Operations” is based on our financial statements included herein, which have been prepared in accordance with GAAP. The preparation of these financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and related disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period (see Note 1, Description of Business and Summary of Significant Accounting Policies, for more information). In preparing our financial statements in accordance with GAAP and pursuant to the rules and regulations of the SEC, we make estimates, assumptions and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosures of contingent assets and liabilities. We base our estimates, assumptions and judgments on historical experience and other factors that we believe are reasonable. We evaluate our estimates, assumptions and judgments regularly and apply our accounting policies consistently. We believe that the estimates, assumptions and judgments involved in the accounting for revenues recognition, goodwill, and income taxes have the most potential impact on our financial statements. Historically, our estimates, assumptions and judgments relative to our critical accounting policies have not differed materially from actual results.
Recent Accounting Pronouncements
Refer to Note 1, Description of Business and Summary of Significant Accounting Policies, to our Unaudited Condensed Financial Statements, included in Part I, Item 1 of this Report for a discussion of applicable recent accounting pronouncements.
Analysis of Quarterly Results from Operations
Total Revenues. The following table presents details of total revenues for the three months ended June 30, 2024 and 2023:
Three Months Ended June 30,$
Increase
(decrease)
%
Change
20242023
(In thousands, except percentages)
Product revenues$24,396 $23,658 $738 3.1 %
Service revenues21,381 19,887 1,494 7.5 %
Total revenues$45,777 $43,545 $2,232 5.1 %
Product revenues primarily consist of product sales, but also includes OEM products for the traffic signal markets, as well as third-party product sales for installation under certain construction-type contracts. Product revenues for the three months ended June 30, 2024 increased 3.1% to $24.4 million, as compared to $23.7 million in the corresponding period in the prior year, primarily due to continued strong demand for our sensors and products families as well as our third-party products.
Service revenues consist of software, managed services, systems integration, and consulting services revenues. In certain instances, the lack of third-party product and/or subcontractor service availability can impact the timing of systems integration projects and associated revenue recognition. Service revenues for the three months ended June 30, 2024 increased 7.5% to $21.4 million, compared to $19.9 million in the corresponding period in the prior year. This increase was due to an increase in subscription revenue for our software products, such as CVIEWPlus and ClearGuide, in addition to an increase in consulting services. Total annual recurring revenue, which we define as revenue from software and managed service contracts, was approximately 26.0% and 24.5% of total revenue for the three-month periods ended June 30, 2024 and June 30, 2023, respectively.
Total revenues for the three months ended June 30, 2024 increased 5.1% to $45.8 million, compared to $43.5 million in the corresponding period in the prior year due to the aforementioned reasons.
27


The Company added approximately $48.8 million of new bookings, or potential revenue under binding agreements, during the first quarter of Fiscal 2025. The Company's total ending backlog increased 2.4% to approximately $126.8 million as of June 30, 2024, as compared to approximately $123.8 million as of June 30, 2023.
Gross Profit and Gross Margin
The following tables present details of our gross profit for the three months ended June 30, 2024 and 2023:
Three Months Ended June 30,$
Increase (decrease)
%
Change
20242023
(In thousands, except percentages)
Product gross profit$11,225$11,554$(329)(2.8)%
Service gross profit6,1155,24986616.5 %
Total gross profit$17,340$16,803$5373.2 %
Product gross margin as a % of product revenues46.0 %48.8 %
Service gross margin as a % of service revenues28.6 %26.4 %
Total gross margin as a % of total revenues37.9 %38.6 %
Our product gross margin as a percentage of product revenues for the three months ended June 30, 2024 decreased approximately 280 basis points compared to the corresponding period in the prior year. The decrease reflects a variety of factors, including the impact of negative current year inventory adjustments and a 117 basis points positive impact on prior year's gross margin from a product return sold previously at a lower than average gross margin. See Litigation and Other Contingencies below for more information.
Our service gross margin as a percentage of service revenues for the three months ended June 30, 2024 increased approximately 220 basis points compared to the corresponding period in the prior year. The increase in service margin was primarily related to improved labor mix and reduced third-party equipment costs compared to the same period in the prior year.
Our total gross margin as a percentage of total revenues for the three months ended June 30, 2024 decreased approximately 70 basis points as compared to the corresponding prior year period due to the aforementioned reasons.
We plan to continue to focus on securing new contracts and to extend and/or continue our existing relationships with both key public-sector and private-sector customers. While we believe our ability to obtain additional large contracts will contribute to overall revenues growth, the mix of subcontractor revenues and third-party product sales to our public-sector customers will likely affect the related total gross profit from period to period, as total revenues derived from subcontractors and third-party product sales generally have lower gross margins than revenues generated by our own products and professional services.
General and Administrative Expense
General and administrative expense for the three months ended June 30, 2024 increased approximately 8.7% to $6.3 million, compared to $5.8 million for the three months ended June 30, 2023. The increase was primarily driven by executive severance and transition costs incurred in the current year.
Sales and Marketing Expense
Sales and marketing expense for the three months ended June 30, 2024 increased approximately 15.3% to $7.3 million compared to $6.3 million for the three months ended June 30, 2023. The increase was primarily due to an increase in headcount and the related employee benefits, as well as higher marketing and sales proposal activity.
Research and Development Expense
Research and development expense for the three months ended June 30, 2024 increased approximately 36.6% to $2.9 million, compared to $2.1 million for the three months ended June 30, 2023. The increase primarily reflects an increase in headcount and related employee benefit expense, and less costs capitalized for internal-use software development.
28


We plan to continue to invest in the development of further enhancements and new functionality of our Iteris ClearMobility Platform, which includes among other things our software portfolio and our Vantage sensors.
We capitalized certain development costs as intangible assets on the Company’s balance sheets in both the current and prior year periods; however, certain development costs did not meet the criteria for capitalization under GAAP and are included in research and development expense. Going forward, we expect to continue to invest in our software solutions. This continued investment may result in increases in research and development costs, as well as additional capitalized software assets in future periods.
Amortization of Intangible Assets
Amortization expense for intangible assets is recorded in both cost of revenues and operating expenses. Total amortization was approximately $1.0 million and $0.8 million for three-month periods ended June 30, 2024 and 2023, respectively.
Other Income, Net
Other income, net, was approximately $0.1 million and $0.2 million for the three-month periods ended June 30, 2024 and 2023, respectively.
Interest Income
Net interest income was approximately $0.1 million for each of the three-month periods ended June 30, 2024 and 2023, with a small increase in the current year masked by rounding. The small current year increase was primarily due to higher cash balance held at banks and the interest rates associated with those accounts when compared to the prior year.
Income Taxes
The effective tax rate used for interim periods is the estimated annual effective tax rate, based on the current estimate of full year results, not including taxes related to specific events. Taxes related to specific events, if any, are recorded in the interim period in which they occur.
Income tax expense for the three months ended June 30, 2024 was less than $0.1 million, or 10.9% of the pretax income as compared with an expense of approximately $0.1 million, or 4.3% of pretax income, for the three months ended June 30, 2023.
In assessing the realizability of our deferred tax assets, we review all available positive and negative evidence, including reversal of deferred tax liabilities, potential carrybacks, projected future taxable income, tax planning strategies and recent financial performance. As the Company has sustained a cumulative pre-tax loss over the trailing three years, we consider it appropriate to maintain a valuation allowance on our deferred tax assets. We recorded a valuation allowance against all of our deferred tax assets as of June 30, 2024, and 2023. We intend to continue maintaining a full valuation allowance on our deferred tax assets until there is sufficient evidence to support the reversal of all or some portion of these allowances. However, given our current earnings and anticipated future earnings, we believe that there is a reasonable possibility that within the next twelve months, sufficient positive evidence may become available to allow us to reach a conclusion that a significant portion of the valuation allowance will no longer be needed. Release of the valuation allowance would result in the recognition of certain deferred tax assets and a decrease to income tax expense for the period the release is recorded. However, the exact timing and amount of the valuation allowance release are subject to change on the basis of the level of profitability that we are able to actually achieve.
29


Litigation and Other Contingencies
As a provider of traffic engineering services, hardware products, software and other various solutions for the traffic industry, the Company is, and may in the future from time to time be, involved in disputes, proceedings, or litigation relating to claims arising out of its operations in the normal course of business, such as intellectual property infringement and contractual matters. In addition, as noted under “Non-GAAP Financial Measures” above, we have been incurring legal expenses, related to a specific breach of contract dispute, that we believe are infrequent, unusual and not reflective of ongoing operating results. While the Company cannot accurately predict the outcome of any such disputes, proceedings, or litigation, including the matter described below, the Company is not a party to any legal dispute, proceeding or litigation, the outcome of which, in management’s opinion, individually or in the aggregate, would have a material adverse effect on the Company’s business, results of operations, financial position or cash flows.
The Company agreed to accept a $1.0 million return of inventory sold by the Company during the three months ended June 30, 2023, at the request of a prime contractor and related to a project that has been delayed and for which there were no known issues with the product. The Company was a subcontractor to the prime contractor on the delayed project. Up to mid-July 2023 the Company believed the probability of the occurrence of a loss associated with this matter was remote. After meeting with the prime contractor beginning in mid-July 2023, the Company agreed to reassess the situation and agreed on August 7, 2023, to accept the inventory return. For the three months ended June 30, 2023, we recognized a pretax loss contingency of $0.2 million, comprised of $1.0 million in accrued liabilities representing the sale value of the inventory and $0.8 million in prepaid expenses and other current assets representing the estimated value of the inventory to be returned in the future. The inventory was returned, and the accrued liability was paid. As of June 30, 2024 and March 31, 2024, there were no outstanding contingencies related to this inventory.
Liquidity and Capital Resources
Cash Flows
We have historically financed our operations with a combination of cash flows from operations and the sale of equity securities. We expect to continue to rely on cash flows from operations and our cash reserves to fund our operations, which we believe to be sufficient to fund our operations for at least the next twelve months. However, we may need or choose to raise additional capital to fund potential future acquisitions and our future growth. We may raise such funds by selling equity or debt securities to the public or to selected investors or by borrowing money from financial institutions. If we raise additional funds by issuing equity or convertible debt securities, our existing stockholders may experience significant dilution, and any equity securities that may be issued may have rights senior to our existing stockholders. There is no assurance that we will be able to secure additional funding on a timely basis, on terms acceptable to us, or at all.
At June 30, 2024, we had $34.3 million in working capital, which included $21.6 million in cash and cash equivalents and restricted cash. This compares to working capital of $32.6 million at March 31, 2024, which included $26.0 million in cash and cash equivalents and restricted cash.
Operating Activities. Net cash used in operating activities for the three months ended June 30, 2024 was $3.6 million, which compares to net cash provided by operating activities of $4.0 million for the same period in the prior year. The $7.6 million year-over-year decrease is primarily due to lower net income and the timing of activity in working capital.
Investing Activities. Net cash used in investing activities during the three months ended June 30, 2024 of $0.1 million, compared to net cash used of $0.8 million for the same period in the prior year. The decrease was largely due to a $0.5 million decrease in capitalized software development costs mainly caused by the deployment of VantageARGUS CV.
Financing Activities. Net cash used in financing activities during the three months ended June 30, 2024 was $0.6 million, which compared to net cash provided by financing activities of $0.3 million for the same period in the prior year. The $0.9 million year-over-year change primarily reflects $0.6 million share repurchase activity and $0.2 million lower proceeds from stock option exercises in the current year.
Off Balance Sheet Arrangements
We did not have any material off balance sheet arrangements as of June 30, 2024.
30


Seasonality
We have historically experienced seasonality, which adversely affects product sales in our third and fourth fiscal quarters due to a reduction in intersection construction and repairs during the winter months due to inclement weather conditions, with the third fiscal quarter generally affected the most by inclement weather. We have also experienced seasonality, particularly with respect to our service revenues, especially in the third fiscal quarter due to the increased number of holidays, causing a reduction in available billable hours.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
As a smaller reporting company, we are not required to provide the information required by Item 305 of Regulation S-K.
ITEM 4. CONTROLS AND PROCEDURES
Evaluation of Disclosure Controls and Procedures
Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act), as of the end of the period covered by this Quarterly Report on Form 10-Q.
Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures are effective at the reasonable assurance level to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, our management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. Our management was required to apply its judgment in evaluating the cost-benefit relationship of such controls and procedures.
Changes in Internal Controls
During the fiscal quarter covered by this report, there has been no change in our internal controls over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that has materially affected, or is reasonably likely to materially affect, our internal controls over financial reporting.
Inherent Limitations on Internal Controls
A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of management override or improper acts, if any, have been detected. These inherent limitations include the realities that judgments in decision making can be faulty, and that breakdowns can occur because of simple errors. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the control. The design of any system of controls is also based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Because of the inherent limitations in a cost-effective control system, misstatements due to management override, error or improper acts may occur and not be detected. Any resulting misstatement or loss may have an adverse and material effect on our business, financial condition and results of operations.
31


PART II. OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
The information set forth in Note 5, Commitments and Contingencies, under the heading “Litigation and Other Contingencies” to our Unaudited Condensed Financial Statements, included in Part I, Item 1 of this report, is incorporated herein by reference.
ITEM 1A. RISK FACTORS
There have been no material changes to the risk factors disclosed in “Item 1A. Risk Factors” of our Annual Report on Form 10-K from the year ended March 31, 2024, filed with the SEC on June 13, 2024. as amended on July 29, 2024 (the “Annual Report”). Refer to Part I, “Item 1A. Risk Factors” in our Annual Report for a discussion of factors that could materially affect our business, financial condition, results of operations, or future results.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES, USE OF PROCEEDS, AND ISSUER PURCHASES OF EQUITY SECURITIES
Recent Sales of Unregistered Securities
Not applicable.
Use of Proceeds from Registered Securities
Not applicable.
Purchases of Equity Securities by the Issuer
During the quarter ended June 30, 2024, we repurchased 146,541 shares for an aggregate price of approximately $0.6 million at an average price of $4.24 per share. See Note 8, Stock Repurchase Program, to the accompanying unaudited condensed financial statements for additional information.
Information regarding the repurchase of common stock during the three months ended June 30, 2024 is as follows:

PeriodTotal Number of Shares PurchasedAverage Price Paid per ShareTotal Number of Shares Purchased as Part of Publicly Announced Program
Approximate Dollar Value of Shares that May Yet Be Purchased Under the Program(1)
(In thousands)
June 1, 2024 to June 30, 2024146,541 $4.24 486,402 $8,312 

1.On May 12, 2022, the Board of Directors approved a repurchase plan for the Company to acquire up to $10 million of its outstanding common stock for an unspecified length of time. All repurchases by the Company during the quarter ended June 30, 2024 were pursuant to the 2022 Stock Repurchase Program.
ITEM 3. DEFAULTS UPON SENIOR SECURITIES
None.
32


ITEM 4. MINE SAFETY DISCLOSURES
Not applicable.
ITEM 5. OTHER INFORMATION
a.None.
b.None.
c.Insider Trading Arrangements
A substantial portion of the compensation of our executive officers is awarded in the form of equity awards, which consist of a mix of stock options, restricted stock units, and performance stock units (“PSUs”). All of these awards vest based on continued service to the Company and over a vesting schedule, with PSUs earned based additionally on performance over a three-year period. We believe equity-based compensation provides our executive officers with a direct interest in our long-term performance and creates an ownership culture that aligns interests between our executive officers and our stockholders. Following delivery of shares of our common stock under such equity awards, once any applicable time and performance-based vesting standards have been met, our executive officers from time to time may engage in the open-market sale of some of those shares for reasons such as satisfying vesting related income tax requirements, investment diversification, or other personal reasons.
Transactions in our securities by our directors and officers are required to be made in accordance with our “Statement of Company Policy - Securities Trading By Company Personnel” (our “Insider Trading Policy”), which, among other things, requires that the transactions be in accordance with applicable U.S. federal securities laws that prohibit trading while in possession of material nonpublic information. Rule 10b5-1 under the Exchange Act provides an affirmative defense that enables directors and officers to prearrange transactions in a company’s securities in a manner that avoids concerns about initiating transactions while in possession of material nonpublic information. Our Insider Trading Policy permits our directors and officers to enter into trading plans designed to comply with Rule 10b5-1. In addition, certain persons are required to maintain an ownership of the Company’s common stock with at least a specified value, which for employees is equal to at least a multiple of their annual base salary (3x annual salary for our Chief Executive Officer and 1x annual salary for all other executive officers), or for non-employee directors is equal to 5x their annual cash retainer.
During the three months ended June 30, 2024, a written trading plan (the “Trading Plan”) was adopted on June 17, 2024 by Joe Bergera, our Chief Executive Officer. The Trading Plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), and only permits trades to be executed when the stock price reaches a required minimum. The plan’s maximum duration is until December 15, 2024, and the first trade will not occur until September 16, 2024, at the earliest. The Trading Plan is intended to facilitate an orderly process to exercise a portion of stock options that will expire in September 2025. As such, Mr. Bergera will sell only enough shares to cover the exercise price and related taxes upon his exercise of stock options, not to exceed 147,600 shares. Mr. Bergera intends to retain all of the remaining shares purchased upon exercise.
During the three months ended June 30, 2024, none of the Company’s directors and no other officers adopted, modified or terminated a Rule 10b5-1 trading arrangement, and none of the Company’s directors or officers adopted, modified or terminated a non-Rule 10b5-1 trading arrangement (as such terms are defined in Item 408 of Regulation S-K of the Securities Act of 1933, as amended).
33


ITEM 6. EXHIBITS
The following exhibits are filed or furnished herewith or are incorporated by reference to the location indicated.
Exhibit
Number
DescriptionWhere Located
3.1Exhibit 3.1 to the Registrant's Current Report on Form 8-K as filed with the SEC on October 15, 2018
3.2Exhibit 3.1 to the Registrant's Quarterly Report on Form 10-Q for the quarter ended June 30, 2018, as filed with the SEC on August 7, 2018
31.1Filed herewith
31.2Filed herewith
32.1Furnished herewith
32.2Furnished herewith
101.INSInline XBRL Instance Document – The instance document does not appear in the interactive data file because its XBRL tags are embedded within the inline XBRL document.Filed herewith
101.SCHInline XBRL Taxonomy Extension Schema DocumentFiled herewith
101.CALInline XBRL Taxonomy Extension Calculation Linkbase DocumentFiled herewith
101.LABInline XBRL Taxonomy Extension Label Linkbase DocumentFiled herewith
101.PREInline XBRL Taxonomy Extension Presentation Linkbase DocumentFiled herewith
101.DEFInline XBRL Taxonomy Extension Definition Linkbase DocumentFiled herewith
104.1Cover Page Interactive Data File – The cover page interactive data file does not appear in the interactive data file because its XBRL tags are embedded within the inline XBRL documentFiled herewith
___________________________________
34


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Date: August 8, 2024ITERIS, INC.
(Registrant)
By/s/ JOE BERGERA
Joe Bergera
Chief Executive Officer
(Principal Executive Officer)
By/s/ KERRY A. SHIBA
Kerry A. Shiba
Chief Financial Officer, Treasurer and Secretary
(Principal Financial and Accounting Officer)
35

EXHIBIT 31.1
CERTIFICATION PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Joe Bergera, certify that:
1.I have reviewed this quarterly report on Form 10-Q of Iteris, Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: August 8, 2024
/s/ JOE BERGERA
Joe Bergera
Chief Executive Officer
(Principal Executive Officer)


EXHIBIT 31.2
CERTIFICATION PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Kerry A. Shiba, certify that:
1.I have reviewed this quarterly report on Form 10-Q of Iteris, Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: August 8, 2024
/s/ KERRY A. SHIBA
Kerry A. Shiba
Senior Vice President and Chief Financial Officer, Treasurer, and Secretary
(Principal Financial and Accounting Officer)


EXHIBIT 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. §1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Iteris, Inc. (the “Company”) on Form 10-Q for the quarter ended June 30, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Joe Bergera, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
1.The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: August 8, 2024
/s/ JOE BERGERA
Joe Bergera
Chief Executive Officer
A signed original of this written statement required by Section 906, or any other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.


EXHIBIT 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. §1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Iteris, Inc. (the “Company”) on Form 10-Q for the quarter ended June 30, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Kerry A. Shiba, Senior Vice President and Chief Financial Officer, Treasurer, and Secretary of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
1.The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: August 8, 2024
/s/ KERRY A. SHIBA
Kerry A. Shiba
Senior Vice President and Chief Financial Officer, Treasurer, and Secretary
A signed original of this written statement required by Section 906, or any other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

v3.24.2.u1
Cover - shares
3 Months Ended
Jun. 30, 2024
Aug. 02, 2024
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Jun. 30, 2024  
Document Transition Report false  
Entity File Number 001-08762  
Entity Registrant Name ITERIS, INC.  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 95-2588496  
Entity Address, Address Line One 1250 S. Capital of Texas Hwy., Building 1  
Entity Address, Address Line Two Suite 330  
Entity Address, City or Town Austin  
Entity Address, State or Province TX  
Entity Address, Postal Zip Code 78746  
City Area Code 512  
Local Phone Number 382-9669  
Title of 12(b) Security Common Stock, $0.10 par value  
Trading Symbol ITI  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   42,822,824
Entity Central Index Key 0000350868  
Amendment Flag false  
Current Fiscal Year End Date --03-31  
Document Fiscal Year Focus 2025  
Document Fiscal Period Focus Q1  
v3.24.2.u1
Unaudited Condensed Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2024
Mar. 31, 2024
Current assets:    
Cash and cash equivalents $ 21,377 $ 25,850
Restricted cash 248 125
Trade accounts receivable, net of allowance for doubtful accounts of $281 and $351 at June 30, 2024 and March 31, 2024, respectively 30,635 25,672
Unbilled accounts receivable 8,386 7,271
Inventories 14,841 13,432
Prepaid expenses and other current assets 3,418 3,581
Total current assets 78,905 75,931
Property and equipment, net 1,288 1,296
Right-of-use assets 6,827 7,237
Intangible assets, net 8,791 9,602
Goodwill 28,340 28,340
Other assets 1,084 1,039
Total assets 125,235 123,445
Current liabilities:    
Trade accounts payable 17,100 15,852
Accrued payroll and related expenses 13,070 12,812
Accrued liabilities 6,535 6,596
Deferred revenues 7,859 8,070
Total current liabilities 44,564 43,330
Lease liabilities 5,857 6,210
Deferred income taxes 538 515
Unrecognized tax benefits 39 39
Other long-term liabilities 3,954 3,444
Total liabilities 54,952 53,538
Commitments and contingencies (Note 5)
Stockholders’ equity:    
Preferred stock, $1.00 par value: Authorized shares — 2,000 Issued and outstanding shares — none 0 0
Common stock, $0.10 par value: Authorized shares - 70,000 at December 31, 2023 and March 31, 2023 Issued and outstanding shares — 42,793 at December 31, 2023 and 42,808 at March 31, 2023 4,301 4,298
Treasury stock (29) (15)
Additional paid-in capital 194,695 194,093
Accumulated deficit (128,684) (128,469)
Total stockholders' equity 70,283 69,907
Total liabilities and stockholders' equity $ 125,235 $ 123,445
v3.24.2.u1
Unaudited Condensed Balance Sheets (Parenthetical) - USD ($)
shares in Thousands, $ in Thousands
Jun. 30, 2024
Mar. 31, 2024
Statement of Financial Position [Abstract]    
Trade accounts receivable, allowance for doubtful accounts $ 281 $ 351
Preferred stock, par value (in dollars per share) $ 1.00 $ 1.00
Preferred stock, authorized (in shares) 2,000 2,000
Preferred stock, issued (in shares) 0 0
Preferred stock, outstanding (in shares) 0 0
Common stock, par value (in dollars per share) $ 0.10 $ 0.10
Common stock, authorized (in shares) 70,000 70,000
Common stock, issued (in shares) 43,006 42,972
Common stock, outstanding (in shares) 43,006 42,972
v3.24.2.u1
Unaudited Condensed Statements of Income - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Total revenues $ 45,777 $ 43,545
Cost of revenues 28,437 26,742
Gross profit 17,340 16,803
Operating expenses:    
General and administrative 6,306 5,801
Sales and marketing 7,250 6,290
Research and development 2,880 2,108
Amortization of intangible assets 651 651
Total operating expenses 17,087 14,850
Operating income 253 1,953
Non-operating income:    
Other income, net 56 199
Interest income, net 131 68
Income before income taxes 440 2,220
Provision for income taxes (48) (95)
Net income $ 392 $ 2,125
Net income per common share    
Basic net income per share (in dollars per share) $ 0.01 $ 0.05
Diluted net income per share (in dollars per share) $ 0.01 $ 0.05
Shares used in basic per share calculations (in shares) 42,969 42,567
Shares used in diluted per share calculations (in shares) 43,970 43,640
Product    
Total revenues $ 24,396 $ 23,658
Cost of revenues 13,171 12,104
Service    
Total revenues 21,381 19,887
Cost of revenues $ 15,266 $ 14,638
v3.24.2.u1
Unaudited Condensed Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Cash flows from operating activities    
Net income $ 392 $ 2,125
Adjustments to reconcile net income to net cash (used in) provided by operating activities:    
Right-of-use asset non-cash expense 539 511
Deferred income taxes 23 22
Depreciation of property and equipment 135 150
Stock-based compensation 595 525
Amortization of intangible assets 982 783
Changes in operating assets and liabilities:    
Trade accounts receivable (4,963) (1,620)
Unbilled accounts receivable and deferred revenues (816) 687
Inventories (1,409) (693)
Prepaid expenses and other assets 118 (1,182)
Trade accounts payable and accrued expenses 1,268 3,354
Operating lease liabilities (482) (616)
Net cash provided by (used in) operating activities (3,618) 4,046
Cash flows from investing activities    
Purchases of property and equipment (24) (168)
Capitalized software development costs (97) (588)
Net cash used in investing activities (121) (756)
Cash flows from financing activities    
Proceeds from stock option exercises 10 257
Tax withholding payments for net share settlements of performance stock units 0 (6)
Repurchases of common stock (621) 0
Net cash (used in) provided by financing activities (611) 251
(Decrease) increase in cash, cash equivalents and restricted cash (4,350) 3,541
Cash, cash equivalents and restricted cash at beginning of period 25,975 16,727
Cash, cash equivalents and restricted cash at end of period 21,625 20,268
Supplemental schedule of non-cash investing and financing activities:    
Lease liabilities arising from obtaining right-of-use assets 129 121
Purchases of fixed assets in accounts payable 103 0
Capitalized software development costs in accounts payable and accrued liabilities $ 74 $ 234
v3.24.2.u1
Unaudited Condensed Statements of Stockholders’ Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Treasury Stock
Additional Paid-In Capital
Accumulated Deficit
Balance (in shares) at Mar. 31, 2023   42,808      
Balance, treasury stock (in shares) at Mar. 31, 2023     369    
Balance at Mar. 31, 2023 $ 62,906 $ 4,282 $ (891) $ 190,082 $ (130,567)
Increase (Decrease) in Stockholders' Equity          
Stock option exercises (in shares)   60      
Stock option exercises 257 $ 6   251  
Issuance of shares pursuant to vesting of restricted stock units, net of payroll withholding taxes (in shares)   1      
Issuance of shares pursuant to vesting of performance stock units, net of payroll withholding taxes (6)     (6)  
Stock-based compensation 525     525  
Net income 2,125       2,125
Balance (in shares) at Jun. 30, 2023   42,869      
Balance, treasury stock (in shares) at Jun. 30, 2023     369    
Balance at Jun. 30, 2023 $ 65,807 $ 4,288 $ (891) 190,852 (128,442)
Balance (in shares) at Mar. 31, 2024 42,972 42,972      
Balance, treasury stock (in shares) at Mar. 31, 2024     148    
Balance at Mar. 31, 2024 $ 69,907 $ 4,298 $ (15) 194,093 (128,469)
Increase (Decrease) in Stockholders' Equity          
Stock option exercises (in shares)   3      
Stock option exercises 10     10  
Issuance of shares pursuant to vesting of restricted stock units, net of payroll withholding taxes (in shares)   31      
Issuance of shares pursuant to vesting of performance stock units, net of payroll withholding taxes 0 $ 3   (3)  
Stock-based compensation 595     595  
Treasury stock purchases (in shares)     147    
Treasury stock purchases (621)   $ (14)   (607)
Net income $ 392       392
Balance (in shares) at Jun. 30, 2024 43,006 43,006      
Balance, treasury stock (in shares) at Jun. 30, 2024     295    
Balance at Jun. 30, 2024 $ 70,283 $ 4,301 $ (29) $ 194,695 $ (128,684)
v3.24.2.u1
Description of Business and Summary of Significant Accounting Policies
3 Months Ended
Jun. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Description of Business and Summary of Significant Accounting Policies Description of Business and Summary of Significant Accounting Policies
Description of Business
Iteris, Inc. (referred to in this report as “Iteris”, the “Company”, “we”, “our”, and “us”) is a provider of smart mobility infrastructure management solutions. Our cloud-enabled solutions help public transportation agencies, municipalities, commercial entities and other transportation infrastructure providers monitor, visualize, and optimize mobility infrastructure to make mobility safe, efficient and sustainable for everyone.
As a pioneer in intelligent transportation systems (“ITS”) technology, our intellectual property, advanced detection sensors, mobility and traffic data, software-as-a-service (“SaaS”) and data-as-a-service ("DaaS") offerings, mobility consulting services, and cloud-enabled managed services represent a comprehensive range of smart mobility infrastructure management solutions that we distribute to customers throughout the United States (“U.S.”) and internationally.
We believe our products, solutions and services increase vehicle and pedestrian safety and decrease congestion within our communities, while also reducing environmental impact, including carbon emissions.
We continue to make significant investments to leverage our existing technologies and further enhance our advanced detection sensors, software as a service portfolio, mobility data sets, mobility consulting services, and cloud-enabled managed services. As we are always mindful of capital allocation, we apply significant effort to evaluate and prioritize these investments. Likewise, we are always exploring strategic alternatives intended to optimize the value of our Company.
Iteris was incorporated in Delaware in 1987 and has operated in its current form since 2004. Our principal executive offices are located at 1250 S Capital of Texas Hwy, Bldg. 1, Suite 330, Austin TX 78746, and our telephone number at that location is (512) 716-0808. Our website address is www.iteris.com. The inclusion of our website address in this report does not include or incorporate by reference into this report any information on, or accessible through, our website. Each of our annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K, together with amendments to these reports, are available on the “Investor Relations” section of our website, free of charge, as soon as reasonably practicable after such material is filed with, or furnished to, the U.S. Securities and Exchange Commission (“SEC”).
Basis of Presentation
Our unaudited condensed financial statements have been prepared in accordance with the rules of the SEC for interim reporting, which permit certain footnotes or other financial information that are normally required by generally accepted accounting principles in the U.S. (“GAAP”) to be condensed or omitted. These unaudited condensed financial statements should be read in conjunction with the Company’s audited financial statements and related notes included in its Annual Report on Form 10-K for Fiscal 2024, filed with the SEC on June 13, 2024, as amended on July 29, 2024. All intercompany accounts and transactions have been eliminated in consolidation. The results of operations for the three months ended June 30, 2024 are not necessarily indicative of the results to be expected for fiscal year ended March 31, 2025 (“Fiscal 2025”) or any other future periods.
Use of Estimates
The preparation of unaudited financial statements in conformity with GAAP requires our management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. Significant estimates made in the preparation of the financial statements include, but are not limited to, recoverability of long-lived and intangible assets; estimates of future cash flows used to assess the recoverability of the impairment of goodwill; projections of taxable income used to assess realizability of deferred tax assets; warranty reserves; costs to complete long-term contracts; indirect cost rates used in cost plus contracts; fair value of stock option awards and equity instruments; and capitalization and estimated useful life of the Company’s internal-use software development costs. Estimates are based on historical experience and on various assumptions that the Company believes are reasonable under current circumstances. However, future events are subject to change and best estimates and judgments may require further adjustments, therefore, actual results could differ materially from those estimates. Management periodically evaluates such estimates, and they are adjusted prospectively based upon such periodic evaluation.
Revenue Recognition
Our revenue arrangements are complex in nature and require significant judgment in determining the performance obligation structure. Each contract is unique in nature and therefore is assessed individually for appropriate accounting treatment.
Revenues are recognized when control of the promised goods or services is transferred to our customers, in an amount that reflects the consideration to which we expect to be entitled in exchange for those goods or services. We generate all of our revenues from contracts with customers, ranging from purchase orders to multi-year agreements.
Product revenue-related contracts with customers begin when we acknowledge a purchase order for a specific customer order of product to be delivered in the near term. These purchase orders are generally short-term in nature. Product revenues are recognized at a point in time upon shipment or upon customer receipt of the product, depending on shipping terms. The Company determined that this method best represents the transfer of goods as transfer of control typically occurs upon shipment or upon customer receipt of the product.
Service revenues include revenues derived from the use of the Company’s service platforms and application programming interfaces on a subscription basis as well as from maintenance and support. We generate these revenues from monthly active user fees, SaaS fees, hosting and storage fees, and maintenance and support fees. In most cases, the subscription or transaction arrangement is a single performance obligation comprising a series of distinct services that are substantially the same and that have the same pattern of transfer (i.e., distinct days of service). The Company applies a time-based measure of progress to the total transaction price, which results in ratable recognition over the term of the contract. The Company determined that this method best represents the transfer of services in these situations as the customer obtains equal benefit from the service throughout the service period.
Service revenues are also derived from engineering and consulting service contracts with governmental agencies. These contracts generally include performance obligations in which control is transferred over time. For fixed fee contracts, we recognize revenues over time using the proportion of actual costs incurred to the total costs expected to complete the contract performance obligation. The Company determined that this method best represents the transfer of services as the proportional cost incurred closely depicts the efforts or inputs completed towards the satisfaction of a fixed fee contract performance obligation. Other contracts can be based on a Time & Materials (“T&M”) and Cost Plus Fixed Fee (“CPFF”) structure, where such contracts are considered to involve variable consideration. However, contractual performance obligations with these fee types qualify for the “Right to Invoice” practical expedient. Under this practical expedient, the Company is allowed to recognize revenues, over time, in the amount to which the Company has a right to invoice. In addition, the Company is not required to estimate such variable consideration upon inception of the contract or reassess the estimate each reporting period. The Company determined that this method best represents the transfer of services as, upon billing, the Company has a right to consideration from a customer in an amount that directly corresponds with the value to the customer of the Company’s performance completed to date.
The Company accounts for individual goods and services separately if they are distinct performance obligations, which often requires significant judgment based upon knowledge of the products and/or services, the solution provided and the structure of the sales contract. In SaaS agreements, we provide a service to the customer that combines the software functionality, maintenance and hosting into a single performance obligation. In product-related contracts, a purchase order may cover different products, each constituting a separate performance obligation.
We generally estimate variable consideration at the most likely amount to which we expect to be entitled and in certain cases based on the expected value, which requires judgment. We include estimated amounts in the transaction price to the extent it is probable that a significant reversal of cumulative revenues recognized will not occur when the uncertainty associated with the variable consideration is resolved. Our estimates of variable consideration and determination of whether to include estimated amounts in the transaction price are based largely on an assessment of our anticipated performance and all information (historical, current and forecasted) that is reasonably available to us. We review and update these estimates on a quarterly basis.
The Company’s typical performance obligations include the following:
Performance Obligation
When Performance
Obligation is Typically
Satisfied
When Payment is
Typically Due
How Standalone
Selling Price is
Typically Estimated
Product Revenues
Standard purchase orders for delivery of a tangible product
Upon shipment (point in time)
Within 30 days of delivery
Observable transactions
Engineering services where the deliverable is considered a product
As work is performed (over time)
Within 30 days of services being invoiced
Estimated using a cost-plus margin approach
Service Revenues
Engineering, managed services, and consulting services
As work is performed (over time)
Within 30 days of services being invoiced
Estimated using a cost-plus margin approach
SaaS
Over the course of the SaaS service once the system is available for use (over time)
At the beginning of the contract period
Estimated using a cost-plus margin approach
Extended warranty serviceOver the course of the extended warranty period (over time)
At the beginning of the contract period
Estimated using a cost-plus margin approach
Disaggregation of Revenues
The Company disaggregates revenues from contracts with customers into product revenues and service revenues.
Trade Accounts Receivable and Contract Balances
We classify our right to consideration in exchange for goods and services as either a receivable or a contract asset. A receivable is a right to consideration that is unconditional (i.e., only the passage of time is required before payment is due). We present such receivables in trade accounts receivable, net in the accompanying balance sheet at their net estimated realizable value.
The Company maintains an allowance for credit losses to provide for the estimated amount of receivables that will not be collected. The Company estimates allowances for expected credit losses on trade accounts receivable and contract assets as required by the Current Expected Credit Loss (“CECL”) model pursuant to Accounting Standards Codification ("ASC") 326 - Financial Instruments - Credit Losses. If warranted, the allowance is increased by the Company’s provision for doubtful accounts, which is charged against income. All recoveries on receivables previously charged off are included in income, while direct charge-offs of receivables are deducted from the allowance.
A contract asset is a right to consideration that is conditional upon factors other than the passage of time. Contract assets are presented as unbilled accounts receivable in the accompanying balance sheet. For example, we would record a contract asset if we record revenues on a professional services engagement, but are not entitled to bill until we achieve specified milestones.
Our contract assets and refund liabilities are reported in a net position on a contract basis at the end of each reporting period. Refund liabilities are consideration received in advance of the satisfaction of performance obligations.
Contract Fulfillment Costs
The Company evaluates whether to capitalize the costs of fulfilling a contract. Such costs would be capitalized when they are not within the scope of other standards and: (1) are directly related to a contract; (2) generate or enhance resources that will be used to satisfy performance obligations; and (3) are expected to be recovered. There were approximately $0.4 million and $0.5 million of contract fulfillment costs as of June 30, 2024 and March 31, 2024, respectively, which are presented in the accompanying unaudited condensed balance sheets as prepaid expense. These costs primarily relate to the satisfaction of performance obligations related to the set-up of SaaS platforms. These costs are amortized on a straight-line basis over the estimated useful life of the SaaS platform.
Transaction Price Allocated to the Remaining Performance Obligations
As of June 30, 2024 and March 31, 2024, the aggregate amount of transaction price allocated to remaining performance obligations was immaterial, primarily as a result of the termination provisions within our contracts, which make the duration of the accounting term of the contract one year or less.
Practical Expedients and Exemptions
T&M and CPFF contracts are considered variable consideration. However, performance obligations with an underlying fee type of T&M or CPFF qualify for the “Right to Invoice” Practical Expedient under ASC 606-10-55-18. Under this practical expedient, the Company is not required to estimate such variable consideration upon inception of the contract or reassess the estimate each reporting period.
The Company utilizes the practical expedient under ASC 606-10-50-14 of not disclosing information about its remaining performance obligations for contracts with an original expected duration (i.e., contract term, determined based on the analysis of termination provisions described above) of 12 months or less.
The Company pays sales commissions on certain sales contracts. These costs are accrued in the same period that the revenues are recorded. Using the practical expedient under ASC 340-40-25-4, the Company recognizes the incremental costs of obtaining a contract as an expense when incurred since the amortization period of the asset that the Company otherwise would have recognized is one year or less.
The Company utilizes the practical expedient under ASC 606-10-25-18B to account for shipping and handling as fulfillment costs, and not a promised service (a revenue element). Shipping and handling costs are included as cost of revenues in the period during which the products ship.
The Company excludes from the transaction price all sales taxes that are assessed by a governmental authority and that are imposed on and concurrent with a specific revenue-producing transaction and collected from a customer (for example, sales, use, value added, and some excise taxes). This employs the practical expedient under ASC 606-10-32-2A. Sales taxes are presented on a net basis (excluded from revenues) in the accompanying statements of income.
Deferred Revenues
Deferred revenue in the accompanying unaudited condensed balance sheets is composed of consideration received in advance of the satisfaction of performance obligations. Deferred revenue that is not expected to be recognized within the next twelve months is included in other long-term liabilities on the accompanying unaudited condensed balance sheets and was $4.0 million and $3.4 million as of June 30, 2024 and March 31, 2024, respectively.
Concentration of Credit Risk
Financial instruments that potentially subject us to a concentration of credit risk consist principally of cash and cash equivalents and trade accounts receivable.
Cash and cash equivalents consist primarily of demand deposits and money market funds maintained with two financial institutions. Deposits held with banks may exceed the amount of insurance provided on such deposits. Generally, these deposits may be redeemed upon demand and are maintained with high quality financial institutions, and therefore are believed to have minimal credit risk. Accounts at each institution are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000. As of June 30, 2024, the Company had approximately $21.1 million of deposits at financial institutions in excess of the FDIC insured limit.
Our accounts receivable are primarily derived from billings with customers located throughout North America. We generally do not require collateral or other security from our North American customers. We maintain an allowance for credit losses, which losses have historically been within management’s expectations.
We currently have, and historically have had, a diverse customer base. For the three months ended June 30, 2024 and 2023, no individual customer represented greater than 10% of our total revenues. As of June 30, 2024 and March 31, 2024, no individual customer represented greater than 10% of our total accounts receivable.
Fair Values of Financial Instruments
The accounting guidance provided in ASC 820, Fair Value Measurement for fair value provides a framework for measuring fair value, clarifies the definition of fair value, and expands disclosures regarding fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the reporting date. The accounting guidance establishes a three-tiered hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value as follows:
Level 1—Unadjusted quoted prices in active markets for identical assets or liabilities accessible to the reporting entity at the measurement date.
Level 2—Observable inputs other than quoted prices in active markets for identical assets or liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
Level 3—Inputs that are generally unobservable and typically reflect management's estimate of assumptions that market participants would use in pricing the assets or liabilities.
The Company applies fair value accounting for all financial instruments on a recurring basis. The Company's financial instruments, which include cash, cash equivalents, accounts receivable and accounts payable are recorded at their carrying amounts, which approximate their fair values due to their short-term nature. All marketable securities are considered to be available-for-sale and recorded at their estimated fair values. In valuing these items, the Company uses inputs and assumptions that market participants would use to determine their fair value, utilizing valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs.
Cash, Cash Equivalents and Restricted Cash
Cash and cash equivalents consist of cash and short-term investments with initial maturities of 90 days or less.
As of June 30, 2024 and March 31, 2024, restricted cash was $0.2 million and $0.1 million, respectively, consisting of cash restricted for share purchases under the Employee Stock Purchase Plan (“ESPP”) (see Note 7, Stock-Based Compensation, for further details on the ESPP).
Cash, cash equivalents and restricted cash presented in the accompanying unaudited condensed statements of cash flows consisted of the following:
June 30,
20242023
(In thousands)
Cash and cash equivalents$21,377 $19,994 
Restricted cash248 274 
$21,625 $20,268 
Allowance for Credit Loss
We record accounts receivable net of the allowance for credit losses. The allowance is established in accordance with the CECL model. We estimate the allowance for credit losses based on the Company’s assessment of its ability to collect on customer accounts receivable. The collectability of our accounts receivable is evaluated through review of outstanding invoices and ongoing credit evaluations of our customers’ financial condition. In cases where we are aware of circumstances that may impair a specific customer’s ability to meet its financial obligations subsequent to the original sale, we will record an allowance against amounts due, and thereby reduce the net recognized accounts receivable to the amount we reasonably believe will be collected. The allowance reflects our best estimate of probable losses associated with the accounts receivable balance. Our assessment is based on historical experience, current information and reasonable and supportable forecasts. Accounts receivables with similar risk characteristics are evaluated collectively and accounts receivables that do not share similar risk characteristics are evaluated individually. Risk characteristics relevant to the Company’s accounts receivable include account balance and aging status. Adjustments to the allowance for credit losses are recorded through bad debt expense, which is included in operating expenses on the accompanying statements of income. The Company writes off accounts receivable against the allowance when it determines that the balance is uncollectible and collection of the receivable is no longer being actively pursued.
Inventories
Inventories consist of raw materials, work-in-process, and finished goods and are stated at the lower of cost or net realizable value. Cost is determined using the first-in, first-out method.
Property and Equipment
Property and equipment are recorded at cost and are depreciated using the straight-line method over the estimated useful life ranging from two to eight years. Leasehold improvements are depreciated over the term of the related lease or the estimated useful life of the improvement, whichever is shorter.
Intangible Assets
Intangible assets with determinable economic lives are carried at cost, less accumulated amortization. Amortization is computed over the estimated useful life of each asset on a straight-line basis. The Company determines the useful lives of identifiable intangible assets after considering the specific facts and circumstances related to each intangible asset. When determining useful life, the Company considers the contractual term of any agreement related to the asset, the historical performance of the asset, the Company's long-term strategy for using the asset, any laws or other local regulations which could impact the useful life of the asset and other economic factors, including competition and specific market conditions. We carry intangible assets without determinable economic lives at cost, and do not amortize them. We review such intangible assets for impairment at least annually.
Capitalized Software Development Cost
The Company accounts for costs incurred to develop software for internal use in accordance with ASC 350-40, Intangibles — Internal Use Software (“ASC 350-40”). Under ASC 350-40, the costs incurred during the application development stage, which include costs of software configuration and interface design, coding, installation and testing are required to be capitalized. Costs incurred during the preliminary project design along with post-implementation stages of internal use software are expensed as incurred and included in research and development in the statements of income.
Goodwill
Goodwill represents the excess of the purchase price over the fair value of net assets acquired in a business combination. We test goodwill for impairment in accordance with the provisions of ASC 350, Intangibles – Goodwill and Other, (“ASC 350”). Goodwill is tested for impairment at least annually at the reporting unit level or whenever events or changes in circumstances indicate that goodwill might be impaired. ASC 350 provides that an entity has the option to first assess qualitative factors to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the fair value of a reporting unit is less than its carrying amount.
The events and circumstances we consider in performing the qualitative assessment include macroeconomic conditions, industry and market considerations, overall financial performance of the reporting units and other relevant entity-specific events. If, after assessing the totality of events or circumstances, an entity determines that it is more likely than not that the fair value of a reporting unit is equal to or exceeds its carrying value, then additional impairment testing is not required. However, if an entity concludes otherwise, then it is required to perform an impairment test, which involves comparing the estimated fair value of a reporting unit with its book value, including goodwill. To estimate the fair value of the reporting unit for the impairment test, the entity can use an income approach, a market approach, or a combination of both. If the estimated fair value exceeds book value, goodwill is not considered to be impaired. If, however, the estimated fair value of a reporting unit is less than its book value, then we recognize an impairment loss equal to the amount that the book value of the reporting unit exceeds its estimated fair value, not to exceed the total amount of goodwill allocated to the reporting unit.
We monitor the indicators for goodwill impairment between annual tests. During the three months ended June 30, 2024 and 2023, we did not recognize an impairment loss for goodwill.
Impairment of Long-Lived Assets
The Company evaluates its long-lived assets, including property, equipment and intangible assets (other than goodwill) for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset might not be recoverable. We determine whether the carrying value of an asset or asset group is recoverable, based on comparisons to undiscounted expected future cash flows we expect the asset or asset group to generate. If an asset is not recoverable, we record an impairment loss equal to the amount by which the carrying value of the asset exceeds its fair value. During the three months ended June 30, 2024 and 2023, we did not recognize an impairment loss to our long-lived and intangible assets.
Income Taxes
We utilize the asset and liability method of accounting for income taxes, under which deferred taxes are determined based on the temporary differences between the financial statement and tax basis of assets and liabilities using tax rates expected to be in effect during the years in which the basis differences reverse. A valuation allowance is recorded when it is more-likely-than-not that some or all of the deferred tax assets will not be realized, which increases our income tax expense in the period such determination is made. As such, as of June 30, 2024, we determined it was appropriate to record a full valuation allowance against our deferred tax assets. We will continuously reassess the appropriateness of maintaining a valuation allowance. We intend to continue maintaining a full valuations allowance on our deferred tax assets until there is sufficient evidence to support the reversal of all or some portion of these allowances. However, given our current earnings and anticipated future earnings, we believe that there is a reasonable possibility that within the next twelve months, sufficient positive evidence may become available to allow us to reach a conclusion that a significant portion of the valuation allowance will no longer be needed. Release of the valuation allowance would result in the recognition of certain deferred tax assets and a decrease to income tax expense for the period the release is recorded. However, the exact timing and amount of the valuation allowance release are subject to change on the basis of the level of profitability that we are able to actually achieve.
Income tax positions must meet a more-likely-than-not recognition threshold to be recognized. Income tax positions that previously failed to meet the more-likely-than-not threshold are recognized in the first subsequent financial reporting period in which that threshold is met. Previously recognized tax positions that no longer meet the more-likely-than-not threshold are derecognized in the first subsequent financial reporting period in which that threshold is no longer met.
Stock-Based Compensation
We record stock-based compensation in our unaudited condensed statements of income as an expense, based on the estimated grant date fair value of our stock-based awards, whereby such fair values are amortized over the requisite service period. Our stock-based awards currently comprise common stock options, restricted stock units and performance stock units. The fair value of our common stock option awards is estimated on the grant date using the Black-Scholes-Merton option-pricing formula. The fair value of our performance stock unit awards is estimated on the grant date using a Monte Carlo simulation model. While the use of these models meets established requirements, the estimated fair values generated by the models might not be indicative of the actual fair values of our awards as it does not consider certain factors important to those awards to employees, such as continued employment and periodic vesting requirements, as well as limited transferability. The fair value of our restricted stock units is based on the closing market price of our common stock on the grant date. If there are any modifications or cancellations of the underlying unvested stock-based awards, we may be required to accelerate, increase or cancel any remaining unearned stock-based compensation expense.
Research and Development Expenditures
We expense research and development expenditures in the period incurred.
Shipping and Handling Costs
We include shipping and handling costs in the cost of revenues in the period during which the products ship.
Sales Taxes
We present sales taxes on a net basis (excluded from revenues) in the statements of income.
Right-of-Use Assets and Lease Liabilities
We determine if an arrangement contains a lease at inception and classify the lease as either an operating or finance lease at its commencement.
Right-of-use assets and lease liabilities are recorded based on the present value of future lease payments, which factors in certain qualifying initial direct costs incurred as well as any lease incentives received. If an implicit rate is not readily determinable, we utilize inputs from third-party lenders to determine the appropriate discount rate. Lease expense for operating lease payments is recognized on a straight-line basis over the lease term. Finance leases incur interest expense using the effective interest method in addition to amortization of the leased asset on straight-line basis, both over the applicable lease term. Lease terms may factor in options to extend or terminate the lease.
We adhere to the short-term lease recognition exemption for all classes of assets (i.e., facilities and equipment). As a result, leases with an initial term of twelve months or less are not recorded on the balance sheet and are recognized on a straight-line basis over the lease term. In addition, for certain equipment leases, we account for lease and non-lease components, such as services, as a single lease component as permitted.
Warranty
We generally provide a two- to three-year warranty on materials and workmanship from the original invoice date on all products manufactured by the Company. Products sold to various original equipment manufacturer customers sometimes carry longer warranties. We will either repair or replace defective products, usually at our option, upon meeting certain criteria. We accrue a provision for the estimated costs that may be incurred for product warranties relating to a product as a component of cost of sales at the time revenues for that product is recognized. The accrued warranty reserve is included within accrued liabilities in the accompanying unaudited condensed balance sheets. We do not provide any service-type warranties.
Repair and Maintenance Costs
We incur repair and maintenance costs in the normal course of business. Should the repair or maintenance result in a permanent improvement to one of our leased facilities, the cost is capitalized as a leasehold improvement and amortized over its useful life or the remainder of the lease period, whichever is shorter. Non-permanent repair and maintenance costs are expensed as incurred.
Loss Contingencies
We are subject to legal actions that arise in the ordinary course of business. The Company recognizes a liability for a contingency when it is probable that liability has been incurred and when the amount of loss can be reasonably estimated. When a range of probable loss can be estimated, the Company accrues the most likely amount of such loss at no less than the minimum of the range. The Company expenses legal defense costs as incurred.
Comprehensive Income
Net income was the same as comprehensive income for the three months ended June 30, 2024 and 2023.
Recent Accounting Pronouncements
In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280), which is intended to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant expenses. This ASU is applicable to our Annual Report on Form 10-K for the fiscal year ending March 31, 2025, and subsequent interim periods. Early adoption is permitted and the amendments in this ASU should be applied retroactively. We are currently evaluating the impact of this ASU on our financial statement disclosures.
In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740), which includes amendments that further enhance income tax disclosures, primarily through standardization and disaggregation of rate reconciliation categories and income taxes paid by jurisdictions. This ASU is applicable to our Annual Report on Form 10-K for the fiscal year ending March 31, 2026. Early adoption is permitted and the amendments in this ASU should be applied prospectively. Retrospective application is permitted. We are currently evaluating the impact of this ASU on our financial statement disclosures.
v3.24.2.u1
Supplemental Financial Information
3 Months Ended
Jun. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Supplemental Financial Information Supplemental Financial Information
Inventories
The following table presents details of our inventories, net:
June 30,
2024
March 31,
2024
(In thousands)
Raw materials$11,514 $9,063 
Work in process185 468 
Finished goods3,142 3,901 
$14,841 $13,432 
Property and Equipment
The following table presents details of our property and equipment, net:
June 30,
2024
March 31,
2024
(In thousands)
Equipment$6,968 $6,871 
Leasehold improvements858 828 
Accumulated depreciation(6,538)(6,403)
$1,288 $1,296 
Depreciation expense was approximately $0.1 million and $0.2 million for the three-month periods ending June 30, 2024 and June 30, 2023, respectively. Depreciation expense is included in cost of revenues and operating expenses in our unaudited condensed statements of income.
Intangible Assets
The following table presents details of our net intangible assets:
June 30, 2024March 31, 2024
Gross
Carrying
Amount
Accumulated
Amortization
Net Book
Value
Gross
Carrying
Amount
Accumulated
Amortization
Net Book
Value
(In thousands)
Technology$5,029 $(4,601)$428 $5,009 $(4,369)$640 
Customer contracts / relationships9,550 (6,136)3,414 9,550 (5,783)3,766 
Trade names and non-compete agreements782 (770)12 782 (770)12 
Capitalized software development costs10,315 (5,378)4,937 10,164 (4,980)5,184 
Total$25,676 $(16,885)$8,791 $25,505 $(15,902)$9,602 
Amortization expense for intangible assets subject to amortization was approximately $1.0 million and $0.8 million for the three-month periods ended June 30, 2024 and 2023, respectively. Of the total amortization expense, approximately $0.3 million and $0.1 million was recorded to cost of revenues for each of the three-month periods ended June 30, 2024 and 2023, respectively, and approximately $0.7 million was recorded to operating expenses for each of these three-month periods.
We have one indefinite useful life intangible asset, with de minimis carrying value, which was included in trade names and non-compete agreements.
As of June 30, 2024, future estimated amortization expense was as follows:
Year Ending March 31,
(In thousands)
2025$2,586 
20262,359 
20272,036 
20281,295 
2029503 
$8,779 
The future estimated amortization expense does not include the indefinite useful life intangible asset described above.
Goodwill
Goodwill was $28.3 million as of June 30, 2024 and March 31, 2024. There was no change to the goodwill carrying value during the three-month period ending June 30, 2024.
Warranty Reserve Activity
Warranty reserve is recorded as accrued liabilities in the accompanying unaudited condensed balance sheets. The following table presents activity related to the warranty reserve:
Three Months Ended
June 30,
20242023
(In thousands)
Balance at beginning of fiscal year$813 $758 
Additions charged to cost of sales48 193 
Warranty claims(5)(96)
Balance at end of reporting period$856 $855 
Earnings Per Share
The following table sets forth the computation of basic and diluted net income per share:
Three Months Ended
June 30,
20242023
(In thousands, except per share amounts)
Numerator:
Net income$392 $2,125 
Denominator:
Weighted average common shares used in basic computation42,969 42,567 
Stock options and other dilutive awards1,001 1,073 
Weighted average common shares used in diluted computation43,970 43,640 
Net income per common share
     Basic net income per share $0.01 $0.05 
     Diluted net income per share $0.01 $0.05 
The following instruments were excluded for purposes of calculating weighted average common share equivalents in the computation of diluted net income per share as their effect would have been anti-dilutive:
Three Months Ended
June 30,
20242023
(In thousands)
Stock options3,677 3,362 
Restricted stock units18 280 
v3.24.2.u1
Fair Value Measurements
3 Months Ended
Jun. 30, 2024
Fair Value Disclosures [Abstract]  
Fair Value Measurements Fair Value Measurements
We measure fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. As described in more detail in Note 1, Description of Business and Summary of Significant Accounting Policies, fair value measurements are based on a three-tier hierarchy that prioritizes the inputs used to measure fair value.
We did not have any material financial assets or liabilities measured at fair value on a recurring basis using Level 3 inputs as of June 30, 2024 or March 31, 2024. Our non-financial assets, such as goodwill, intangible assets and property and equipment, are measured at fair value on a nonrecurring basis, generally when there is a transaction involving those assets such as a purchase transaction, a business combination or an adjustment for impairment. No non-financial assets were measured at fair value at June 30, 2024 and March 31, 2024.
The following tables present the Company’s financial assets and liabilities that are recorded at fair value on a recurring basis, segregated among the appropriate levels within the fair value hierarchy:
As of June 30, 2024
Amortized
Cost
Gross
Unrealized
Loss
Gross
Unrealized
Gain
Estimated Fair
Value
(In thousands)
Assets:
Level 1:
Securities held in deferred compensation plan (1)
$1,461 $(681)$843 $1,623 
Liabilities:
Level 1:
Deferred compensation plan liabilities (2)
$1,474 $(535)$702 $1,641 
As of March 31, 2024
Amortized
Cost
Gross
Unrealized
Loss
Gross
Unrealized
Gain
Estimated Fair
Value
(In thousands)
Assets:
Level 1:
Securities held in deferred compensation plan (1)
$1,539 $(542)$650 $1,647 
Liabilities:
Level 1:
Deferred compensation plan liabilities (2)
$1,415 $(485)$633 $1,563 
(1) Included in prepaid expenses and other current assets on the Company’s balance sheets.
(2) Included in accrued payroll and related expenses on the Company’s balance sheets.
Unrealized losses related to investments are due to interest rate fluctuations as opposed to credit quality. In addition, we do not intend to sell, nor is it more likely than not that we would be required to sell, any of our investments before recovery of their cost basis. As a result, there was no other-than-temporary impairment for these investments as of June 30, 2024.
v3.24.2.u1
Income Taxes
3 Months Ended
Jun. 30, 2024
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
The effective tax rate used for interim periods is the estimated annual effective tax rate, based on the current estimate of full year results, not including taxes related to specific events. Taxes relate to specific events, if any, are recorded in the interim period in which they occur.
Income tax expense for the three months ended June 30, 2024 was less than $0.1 million, or 10.9% of the pretax income, as compared with an expense of approximately $0.1 million, or 4.3% of pretax income, for the three months ended June 30, 2023.
In assessing the realizability of our deferred tax assets, we review all available positive and negative evidence, including reversal of deferred tax liabilities, potential carrybacks, projected future taxable income, tax planning strategies and recent financial performance. As the Company has sustained a cumulative pre-tax loss over the trailing three years, we consider it appropriate to maintain a valuation allowance on our deferred tax assets. We recorded a valuation allowance against all of our deferred tax assets as of June 30, 2024, and March 31, 2024. We intend to continue maintaining a full valuation allowance on our deferred tax assets until there is sufficient evidence to support the reversal of all or some portion of these allowances. However, given our current earnings and anticipated future earnings, we believe that there is a reasonable possibility that within the next twelve months, sufficient positive evidence may become available to allow us to reach a conclusion that a significant portion of the valuation allowance will no longer be needed. Release of the valuation allowance would result in the recognition of certain deferred tax assets and a decrease to income tax expense for the period the release is recorded. However, the exact timing and amount of the valuation allowance release are subject to change on the basis of the level of profitability that we are able to actually achieve.
v3.24.2.u1
Commitments and Contingencies
3 Months Ended
Jun. 30, 2024
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies
Litigation and Other Contingencies
As a provider of traffic engineering services, hardware products, software and other various solutions for the traffic industry, the Company is, and may in the future from time to time, be involved in disputes, proceedings, or litigation relating to claims arising out of its operations in the normal course of business, such as intellectual property infringement and contractual matters. While the Company cannot accurately predict the outcome of any such disputes, proceedings, or litigation, the Company is not a party to any legal dispute, proceeding, or litigation, the outcome of which, in management’s opinion, individually or in the aggregate, would have a material adverse effect on the Company’s business, results of operations, financial position or cash flows.
The Company agreed to accept a $1.0 million return of inventory sold by the Company during the three months ended June 30, 2023, at the request of a prime contractor and related to a project that has been delayed and for which there were no known issues with the product. The Company was a subcontractor to the prime contractor on the delayed project. Up to mid-July 2023 the Company believed the probability of the occurrence of a loss associated with this matter was remote. After meeting with the prime contractor beginning in mid-July 2023, the Company agreed to reassess the situation and agreed on August 7, 2023, to accept the inventory return. For the three months ended June 30, 2023, we recognized a pretax loss contingency of $0.2 million, $1.0 million in accrued liabilities representing the sale value of the inventory and $0.8 million in prepaid expenses and other current assets representing the estimated value of the inventory to be returned in the future. The inventory was returned, and the accrued liability was paid. As of June 30, 2024 and March 31, 2024, there were no outstanding contingencies related to this inventory.
v3.24.2.u1
Right-of-Use Assets and Lease Liabilities
3 Months Ended
Jun. 30, 2024
Lessee Disclosure [Abstract]  
Right-of-Use Assets and Lease Liabilities Right-of-Use Assets and Lease Liabilities
We have various operating leases for our offices, office equipment and vehicles in the United States. These leases expire at various times through 2030. Certain lease agreements contain renewal options from 1 year to 5 years, rent abatement, and escalation clauses that are factored into our determination of lease payments when appropriate.
The table below presents lease-related assets and liabilities recorded on the unaudited condensed balance sheet as follows:
ClassificationJune 30, 2024March 31, 2024
(In thousands)
Assets
Operating lease right-of-use-assetsRight-of-use assets$6,827 $7,237 
Total operating lease right-of-use-assets$6,827 $7,237 
Liabilities
Operating lease liabilities (short-term)Accrued liabilities$2,176 $2,233 
Operating lease liabilities (long-term)Lease liabilities5,857 6,210 
Total lease liabilities$8,033 $8,443 

Lease Costs
We recorded approximately $0.6 million of lease costs in our unaudited condensed statements of income for each of the three months ended June 30, 2024 and 2023.
Supplemental Information
Information related to the Company right-of-use assets and related operating lease liabilities were as follows:
Three Months Ended
June 30,
(Dollars in thousands)
20242023
Cash paid for amounts included in the measurement of operating lease liabilities $815$673
Weighted average remaining lease term (in years)3.523.90
Weighted average discount rate5.0 %4.7 %
Undiscounted Cash Flows
The table below reconciles the undiscounted cash flows for each of the next five years and the total of the remaining years to the operating lease liabilities recorded on the balance sheet as of June 30, 2024:
Fiscal Year Ending March 31,Operating Leases
(In thousands)
2025$1,931 
20262,436 
20262,498 
20281,447 
2029293 
Thereafter188 
Total lease payments8,793 
Less imputed interest(760)
Present value of future lease payments8,033 
Less current obligations under leases(2,176)
Long-term lease obligations$5,857 
v3.24.2.u1
Stock-Based Compensation
3 Months Ended
Jun. 30, 2024
Share-Based Payment Arrangement [Abstract]  
Stock-Based Compensation Stock-Based Compensation
We currently maintain two stock incentive plans, the 2007 Omnibus Incentive Plan and the 2016 Omnibus Incentive Plan (the “2016 Plan”). Of these plans, we may only grant future awards from the 2016 Plan. The 2016 Plan allows for the issuance of stock options, stock appreciation rights, restricted stock, time-restricted stock units (“RSUs”), performance-based restricted stock units (“PSUs”), cash incentive awards and other stock-based awards. At June 30, 2024, there were approximately 1.1 million shares of common stock available for grant or issuance under the 2016 Plan. Total stock options vested and expected to vest were approximately 6.2 million as of June 30, 2024.
Stock Options
A summary of activity with respect to our stock options for the three months ended June 30, 2024 is as follows:
SharesWeighted-
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Life
Aggregate
Intrinsic
Value
(In thousands)(Years)(In thousands)
Options outstanding at March 31, 20245,858 $4.11 
Granted369 4.21 
Exercised(3)3.47 
Forfeited(67)4.02 
Expired(3)4.79 
Options outstanding at June 30, 20246,154 4.12 5.4$3,484 
Options vested and exercisable at June 30, 20244,267 4.15 4.0$2,647 
Restricted Stock Units
A summary of activity with respect to our RSUs, which entitle the holder to receive one share of our common stock for each RSU upon vesting, for the three months ended June 30, 2024 is as follows:
SharesWeighted-Average
Grant Date
Fair Value
(In thousands)
RSUs outstanding at March 31, 2024793 $4.18 
Granted110 4.27 
Vested and released— — 
Forfeited(24)3.49 
RSUs outstanding at June 30, 2024879 4.21 
Performance Stock Units
The Company approves a “target” number of PSUs for our executive officers with performance and service-based vesting conditions. The actual number of units that ultimately vest will range from 0% to 200% of the original units awarded based on level of achievement. Between 0% and 160% of the PSUs will be eligible to vest based on annual performance during the three-year performance period relative to the revenues per share and cash flow from operations objectives to be established by the Compensation Committee at the beginning of each fiscal year. In addition, the final PSU vesting based on the revenues per share and cash flow from operations performance will be subject to a modifier between 0.75x and 1.25x based on the Company's total shareholder return relative to the Russell 2000 during the performance period, for a maximum achievement percentage of 200% of the "target" number of PSUs. The PSUs are amortized over a service period of three years. We estimated the value and the derived service period of the PSUs using the Monte Carlo simulation model.
In accordance with ASC 718 - Compensation – Stock Compensation, grant date is the date at which the grantor and the grantee reach a mutual understanding of the key terms and conditions of a share-based payment award. For PSU awards with performance conditions to be established by the Compensation Committee at a future date, the grant date does not occur until the vesting conditions are established and communicated to the employees.
The following table summarizes the details of the performance stock units:
SharesWeighted-Average
Grant Date
Fair Value
(In thousands)
PSUs outstanding at March 31, 2024117 $4.75 
Granted83 4.55 
Vested and released(31)5.02 
Forfeited(14)6.16 
PSUs outstanding at June 30, 2024155 4.43 
Stock-Based Compensation Expense
The following table presents stock-based compensation expense that is included in each line item on our unaudited condensed statements of income:
Three Months Ended
June 30,
20242023
(In thousands)
Cost of revenues$89 $85 
General and administrative361 202 
Sales and marketing55 134 
Research and development90 104 
Total stock-based compensation$595 $525 
As of June 30, 2024, there was approximately $3.3 million, $1.8 million and $0.5 million of unrecognized compensation expense related to unvested stock options, RSUs and PSUs, respectively. This expense is currently expected to be recognized over a weighted average period of approximately 2.6 years for stock options, 1.7 years for RSUs and 2.1 years for PSUs. If there are any modifications or cancellations of the underlying unvested awards, we may be required to accelerate, increase or cancel any remaining unearned stock-based compensation expense. Future stock-based compensation expense and unearned stock-based compensation will increase to the extent that we grant additional stock options, RSUs or other stock-based awards.
Other Stock-Based Compensation Plans
We currently maintain an Employee Stock Purchase Plan that allows employees to have a percentage of their base compensation withheld to purchase the Company’s common stock at 95% of the lower of the fair market price at the beginning of the offering period or on the last trading day of the offering period. There are two offering periods during a calendar year, which consist of the six months beginning each January 1 and July 1. Employees may contribute 1-15% of their eligible gross pay up to a $0.03 million annual stock value limit. No shares were purchased during the three months ended June 30, 2024 and June 30, 2023 for the first offerings periods of Fiscal 2025 and 2024.
Deferred Compensation Plan
Effective October 1, 2020, the Company adopted the Iteris, Inc. Deferred Compensation Plan (the “DC Plan”). The DC Plan consists of two plans, one that is intended to be an unfunded arrangement for eligible employees who are part of a select group of management or highly compensated employees of the Company within the meaning of Sections 201(2), 301(a)(3) and 401(a)(1) of ERISA, and one for the benefit of non-employee members of our board of directors. Key employees, including our executive officers, and our non-employee directors who are notified regarding their eligibility to participate and delivered the DC Plan enrollment materials are eligible to participate in the DC Plan. Under the DC Plan, we provide participants with the opportunity to make annual elections to defer a percentage of their eligible cash compensation and equity awards. A participant is always 100% vested in his or her own elective cash deferrals and any earnings thereon. Elective deferrals of equity awards are credited to a bookkeeping account established in the name of the participant with respect to an equivalent number of shares of our common stock, and such credited shares are subject to the same vesting conditions as are applicable to the equity award subject to the election. The Company established a rabbi trust to finance our obligations under the DC Plan with corporate-owned life insurance policies on participants, and the assets held within this trust are subject to the claims of the Company's creditors. The assets and liabilities are recorded at their fair value, which represents their respective amortized cost values plus any unrealized gains or losses. Refer to Note 3, Fair Value Measurements, for further detail on the DC Plan.
v3.24.2.u1
Stock Repurchase Program
3 Months Ended
Jun. 30, 2024
Equity [Abstract]  
Stock Repurchase Program Stock Repurchase Program
On May 12, 2022, the Board of Directors approved a new plan for the Company to acquire up to $10.0 million of its outstanding common stock for an unspecified length of time (the "2022 Stock Repurchase Program"). Under the 2022 Stock Repurchase Program, we may repurchase shares from time to time in the open market and in privately negotiated transactions and block trades and may also repurchase shares pursuant to a 10b5-1 trading plan during our closed trading windows. There is no guarantee as to the exact number of shares that will be repurchased. We may modify or terminate the 2022 Stock Repurchase Program at any time without prior notice.
During the quarter ended June 30, 2024, we repurchased 146,541 shares for an aggregate price of approximately $0.6 million at an average price of $4.24 per share. From the inception of the 2022 Stock Repurchase Program through June 30, 2024, we repurchased approximately 486,402 shares of our common stock for an aggregate price of approximately $1.7 million, at an average price per share of $3.47. As of June 30, 2024, 339,861 repurchased shares have been retired and resumed their status as authorized and unissued shares of our common stock. As of the quarter ended June 30, 2024, approximately $8.3 million remained available for the repurchase of our common stock under our 2022 Stock Repurchase Program.
v3.24.2.u1
Business Segments
3 Months Ended
Jun. 30, 2024
Segment Reporting [Abstract]  
Business Segments Business Segments
The Company's Chief Operating Decision Maker (“CODM”), who is our Chief Executive Officer, reviews the Company's results on a consolidated basis and our financial results are presented under a single reportable segment to provide the most accurate representation of the Company's performance.
v3.24.2.u1
Pay vs Performance Disclosure - USD ($)
$ in Thousands
3 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Pay vs Performance Disclosure    
Net income $ 392 $ 2,125
v3.24.2.u1
Insider Trading Arrangements
3 Months Ended
Jun. 30, 2024
shares
Trading Arrangements, by Individual  
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
Joe Bergera [Member]  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement During the three months ended June 30, 2024, a written trading plan (the “Trading Plan”) was adopted on June 17, 2024 by Joe Bergera, our Chief Executive Officer. The Trading Plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), and only permits trades to be executed when the stock price reaches a required minimum. The plan’s maximum duration is until December 15, 2024, and the first trade will not occur until September 16, 2024, at the earliest. The Trading Plan is intended to facilitate an orderly process to exercise a portion of stock options that will expire in September 2025. As such, Mr. Bergera will sell only enough shares to cover the exercise price and related taxes upon his exercise of stock options, not to exceed 147,600 shares. Mr. Bergera intends to retain all of the remaining shares purchased upon exercise.
Name Joe Bergera
Title Chief Executive Officer
Rule 10b5-1 Arrangement Adopted true
Adoption Date June 17, 2024
Expiration Date December 15, 2024
Arrangement Duration 90 days
Aggregate Available 147,600
v3.24.2.u1
Description of Business and Summary of Significant Accounting Policies (Policies)
3 Months Ended
Jun. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis of Presentation
Basis of Presentation
Our unaudited condensed financial statements have been prepared in accordance with the rules of the SEC for interim reporting, which permit certain footnotes or other financial information that are normally required by generally accepted accounting principles in the U.S. (“GAAP”) to be condensed or omitted. These unaudited condensed financial statements should be read in conjunction with the Company’s audited financial statements and related notes included in its Annual Report on Form 10-K for Fiscal 2024, filed with the SEC on June 13, 2024, as amended on July 29, 2024. All intercompany accounts and transactions have been eliminated in consolidation. The results of operations for the three months ended June 30, 2024 are not necessarily indicative of the results to be expected for fiscal year ended March 31, 2025 (“Fiscal 2025”) or any other future periods.
Use of Estimates
Use of Estimates
The preparation of unaudited financial statements in conformity with GAAP requires our management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. Significant estimates made in the preparation of the financial statements include, but are not limited to, recoverability of long-lived and intangible assets; estimates of future cash flows used to assess the recoverability of the impairment of goodwill; projections of taxable income used to assess realizability of deferred tax assets; warranty reserves; costs to complete long-term contracts; indirect cost rates used in cost plus contracts; fair value of stock option awards and equity instruments; and capitalization and estimated useful life of the Company’s internal-use software development costs. Estimates are based on historical experience and on various assumptions that the Company believes are reasonable under current circumstances. However, future events are subject to change and best estimates and judgments may require further adjustments, therefore, actual results could differ materially from those estimates. Management periodically evaluates such estimates, and they are adjusted prospectively based upon such periodic evaluation.
Revenue Recognition
Revenue Recognition
Our revenue arrangements are complex in nature and require significant judgment in determining the performance obligation structure. Each contract is unique in nature and therefore is assessed individually for appropriate accounting treatment.
Revenues are recognized when control of the promised goods or services is transferred to our customers, in an amount that reflects the consideration to which we expect to be entitled in exchange for those goods or services. We generate all of our revenues from contracts with customers, ranging from purchase orders to multi-year agreements.
Product revenue-related contracts with customers begin when we acknowledge a purchase order for a specific customer order of product to be delivered in the near term. These purchase orders are generally short-term in nature. Product revenues are recognized at a point in time upon shipment or upon customer receipt of the product, depending on shipping terms. The Company determined that this method best represents the transfer of goods as transfer of control typically occurs upon shipment or upon customer receipt of the product.
Service revenues include revenues derived from the use of the Company’s service platforms and application programming interfaces on a subscription basis as well as from maintenance and support. We generate these revenues from monthly active user fees, SaaS fees, hosting and storage fees, and maintenance and support fees. In most cases, the subscription or transaction arrangement is a single performance obligation comprising a series of distinct services that are substantially the same and that have the same pattern of transfer (i.e., distinct days of service). The Company applies a time-based measure of progress to the total transaction price, which results in ratable recognition over the term of the contract. The Company determined that this method best represents the transfer of services in these situations as the customer obtains equal benefit from the service throughout the service period.
Service revenues are also derived from engineering and consulting service contracts with governmental agencies. These contracts generally include performance obligations in which control is transferred over time. For fixed fee contracts, we recognize revenues over time using the proportion of actual costs incurred to the total costs expected to complete the contract performance obligation. The Company determined that this method best represents the transfer of services as the proportional cost incurred closely depicts the efforts or inputs completed towards the satisfaction of a fixed fee contract performance obligation. Other contracts can be based on a Time & Materials (“T&M”) and Cost Plus Fixed Fee (“CPFF”) structure, where such contracts are considered to involve variable consideration. However, contractual performance obligations with these fee types qualify for the “Right to Invoice” practical expedient. Under this practical expedient, the Company is allowed to recognize revenues, over time, in the amount to which the Company has a right to invoice. In addition, the Company is not required to estimate such variable consideration upon inception of the contract or reassess the estimate each reporting period. The Company determined that this method best represents the transfer of services as, upon billing, the Company has a right to consideration from a customer in an amount that directly corresponds with the value to the customer of the Company’s performance completed to date.
The Company accounts for individual goods and services separately if they are distinct performance obligations, which often requires significant judgment based upon knowledge of the products and/or services, the solution provided and the structure of the sales contract. In SaaS agreements, we provide a service to the customer that combines the software functionality, maintenance and hosting into a single performance obligation. In product-related contracts, a purchase order may cover different products, each constituting a separate performance obligation.
We generally estimate variable consideration at the most likely amount to which we expect to be entitled and in certain cases based on the expected value, which requires judgment. We include estimated amounts in the transaction price to the extent it is probable that a significant reversal of cumulative revenues recognized will not occur when the uncertainty associated with the variable consideration is resolved. Our estimates of variable consideration and determination of whether to include estimated amounts in the transaction price are based largely on an assessment of our anticipated performance and all information (historical, current and forecasted) that is reasonably available to us. We review and update these estimates on a quarterly basis.
The Company’s typical performance obligations include the following:
Performance Obligation
When Performance
Obligation is Typically
Satisfied
When Payment is
Typically Due
How Standalone
Selling Price is
Typically Estimated
Product Revenues
Standard purchase orders for delivery of a tangible product
Upon shipment (point in time)
Within 30 days of delivery
Observable transactions
Engineering services where the deliverable is considered a product
As work is performed (over time)
Within 30 days of services being invoiced
Estimated using a cost-plus margin approach
Service Revenues
Engineering, managed services, and consulting services
As work is performed (over time)
Within 30 days of services being invoiced
Estimated using a cost-plus margin approach
SaaS
Over the course of the SaaS service once the system is available for use (over time)
At the beginning of the contract period
Estimated using a cost-plus margin approach
Extended warranty serviceOver the course of the extended warranty period (over time)
At the beginning of the contract period
Estimated using a cost-plus margin approach
Disaggregation of Revenues
The Company disaggregates revenues from contracts with customers into product revenues and service revenues.
Trade Accounts Receivable and Contract Balances
We classify our right to consideration in exchange for goods and services as either a receivable or a contract asset. A receivable is a right to consideration that is unconditional (i.e., only the passage of time is required before payment is due). We present such receivables in trade accounts receivable, net in the accompanying balance sheet at their net estimated realizable value.
The Company maintains an allowance for credit losses to provide for the estimated amount of receivables that will not be collected. The Company estimates allowances for expected credit losses on trade accounts receivable and contract assets as required by the Current Expected Credit Loss (“CECL”) model pursuant to Accounting Standards Codification ("ASC") 326 - Financial Instruments - Credit Losses. If warranted, the allowance is increased by the Company’s provision for doubtful accounts, which is charged against income. All recoveries on receivables previously charged off are included in income, while direct charge-offs of receivables are deducted from the allowance.
A contract asset is a right to consideration that is conditional upon factors other than the passage of time. Contract assets are presented as unbilled accounts receivable in the accompanying balance sheet. For example, we would record a contract asset if we record revenues on a professional services engagement, but are not entitled to bill until we achieve specified milestones.
Our contract assets and refund liabilities are reported in a net position on a contract basis at the end of each reporting period. Refund liabilities are consideration received in advance of the satisfaction of performance obligations.
Contract Fulfillment Costs
The Company evaluates whether to capitalize the costs of fulfilling a contract. Such costs would be capitalized when they are not within the scope of other standards and: (1) are directly related to a contract; (2) generate or enhance resources that will be used to satisfy performance obligations; and (3) are expected to be recovered. There were approximately $0.4 million and $0.5 million of contract fulfillment costs as of June 30, 2024 and March 31, 2024, respectively, which are presented in the accompanying unaudited condensed balance sheets as prepaid expense. These costs primarily relate to the satisfaction of performance obligations related to the set-up of SaaS platforms. These costs are amortized on a straight-line basis over the estimated useful life of the SaaS platform.
Transaction Price Allocated to the Remaining Performance Obligations
As of June 30, 2024 and March 31, 2024, the aggregate amount of transaction price allocated to remaining performance obligations was immaterial, primarily as a result of the termination provisions within our contracts, which make the duration of the accounting term of the contract one year or less.
Practical Expedients and Exemptions
T&M and CPFF contracts are considered variable consideration. However, performance obligations with an underlying fee type of T&M or CPFF qualify for the “Right to Invoice” Practical Expedient under ASC 606-10-55-18. Under this practical expedient, the Company is not required to estimate such variable consideration upon inception of the contract or reassess the estimate each reporting period.
The Company utilizes the practical expedient under ASC 606-10-50-14 of not disclosing information about its remaining performance obligations for contracts with an original expected duration (i.e., contract term, determined based on the analysis of termination provisions described above) of 12 months or less.
The Company pays sales commissions on certain sales contracts. These costs are accrued in the same period that the revenues are recorded. Using the practical expedient under ASC 340-40-25-4, the Company recognizes the incremental costs of obtaining a contract as an expense when incurred since the amortization period of the asset that the Company otherwise would have recognized is one year or less.
The Company utilizes the practical expedient under ASC 606-10-25-18B to account for shipping and handling as fulfillment costs, and not a promised service (a revenue element). Shipping and handling costs are included as cost of revenues in the period during which the products ship.
The Company excludes from the transaction price all sales taxes that are assessed by a governmental authority and that are imposed on and concurrent with a specific revenue-producing transaction and collected from a customer (for example, sales, use, value added, and some excise taxes). This employs the practical expedient under ASC 606-10-32-2A. Sales taxes are presented on a net basis (excluded from revenues) in the accompanying statements of income.
Deferred Revenues
Deferred Revenues
Deferred revenue in the accompanying unaudited condensed balance sheets is composed of consideration received in advance of the satisfaction of performance obligations. Deferred revenue that is not expected to be recognized within the next twelve months is included in other long-term liabilities on the accompanying unaudited condensed balance sheets and was $4.0 million and $3.4 million as of June 30, 2024 and March 31, 2024, respectively.
Concentration of Credit Risk
Concentration of Credit Risk
Financial instruments that potentially subject us to a concentration of credit risk consist principally of cash and cash equivalents and trade accounts receivable.
Cash and cash equivalents consist primarily of demand deposits and money market funds maintained with two financial institutions. Deposits held with banks may exceed the amount of insurance provided on such deposits. Generally, these deposits may be redeemed upon demand and are maintained with high quality financial institutions, and therefore are believed to have minimal credit risk. Accounts at each institution are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000. As of June 30, 2024, the Company had approximately $21.1 million of deposits at financial institutions in excess of the FDIC insured limit.
Our accounts receivable are primarily derived from billings with customers located throughout North America. We generally do not require collateral or other security from our North American customers. We maintain an allowance for credit losses, which losses have historically been within management’s expectations.
We currently have, and historically have had, a diverse customer base. For the three months ended June 30, 2024 and 2023, no individual customer represented greater than 10% of our total revenues. As of June 30, 2024 and March 31, 2024, no individual customer represented greater than 10% of our total accounts receivable.
Fair Values of Financial Instruments
Fair Values of Financial Instruments
The accounting guidance provided in ASC 820, Fair Value Measurement for fair value provides a framework for measuring fair value, clarifies the definition of fair value, and expands disclosures regarding fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the reporting date. The accounting guidance establishes a three-tiered hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value as follows:
Level 1—Unadjusted quoted prices in active markets for identical assets or liabilities accessible to the reporting entity at the measurement date.
Level 2—Observable inputs other than quoted prices in active markets for identical assets or liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
Level 3—Inputs that are generally unobservable and typically reflect management's estimate of assumptions that market participants would use in pricing the assets or liabilities.
The Company applies fair value accounting for all financial instruments on a recurring basis. The Company's financial instruments, which include cash, cash equivalents, accounts receivable and accounts payable are recorded at their carrying amounts, which approximate their fair values due to their short-term nature. All marketable securities are considered to be available-for-sale and recorded at their estimated fair values. In valuing these items, the Company uses inputs and assumptions that market participants would use to determine their fair value, utilizing valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs.
Cash, Cash Equivalents and Restricted Cash
Cash, Cash Equivalents and Restricted Cash
Cash and cash equivalents consist of cash and short-term investments with initial maturities of 90 days or less.
As of June 30, 2024 and March 31, 2024, restricted cash was $0.2 million and $0.1 million, respectively, consisting of cash restricted for share purchases under the Employee Stock Purchase Plan (“ESPP”) (see Note 7, Stock-Based Compensation, for further details on the ESPP).
Allowance for Credit Loss
Allowance for Credit Loss
We record accounts receivable net of the allowance for credit losses. The allowance is established in accordance with the CECL model. We estimate the allowance for credit losses based on the Company’s assessment of its ability to collect on customer accounts receivable. The collectability of our accounts receivable is evaluated through review of outstanding invoices and ongoing credit evaluations of our customers’ financial condition. In cases where we are aware of circumstances that may impair a specific customer’s ability to meet its financial obligations subsequent to the original sale, we will record an allowance against amounts due, and thereby reduce the net recognized accounts receivable to the amount we reasonably believe will be collected. The allowance reflects our best estimate of probable losses associated with the accounts receivable balance. Our assessment is based on historical experience, current information and reasonable and supportable forecasts. Accounts receivables with similar risk characteristics are evaluated collectively and accounts receivables that do not share similar risk characteristics are evaluated individually. Risk characteristics relevant to the Company’s accounts receivable include account balance and aging status. Adjustments to the allowance for credit losses are recorded through bad debt expense, which is included in operating expenses on the accompanying statements of income. The Company writes off accounts receivable against the allowance when it determines that the balance is uncollectible and collection of the receivable is no longer being actively pursued.
Inventories
Inventories
Inventories consist of raw materials, work-in-process, and finished goods and are stated at the lower of cost or net realizable value. Cost is determined using the first-in, first-out method.
Property and Equipment
Property and Equipment
Property and equipment are recorded at cost and are depreciated using the straight-line method over the estimated useful life ranging from two to eight years. Leasehold improvements are depreciated over the term of the related lease or the estimated useful life of the improvement, whichever is shorter.
Intangible Assets
Intangible Assets
Intangible assets with determinable economic lives are carried at cost, less accumulated amortization. Amortization is computed over the estimated useful life of each asset on a straight-line basis. The Company determines the useful lives of identifiable intangible assets after considering the specific facts and circumstances related to each intangible asset. When determining useful life, the Company considers the contractual term of any agreement related to the asset, the historical performance of the asset, the Company's long-term strategy for using the asset, any laws or other local regulations which could impact the useful life of the asset and other economic factors, including competition and specific market conditions. We carry intangible assets without determinable economic lives at cost, and do not amortize them. We review such intangible assets for impairment at least annually.
Capitalized Software Development Cost
Capitalized Software Development Cost
The Company accounts for costs incurred to develop software for internal use in accordance with ASC 350-40, Intangibles — Internal Use Software (“ASC 350-40”). Under ASC 350-40, the costs incurred during the application development stage, which include costs of software configuration and interface design, coding, installation and testing are required to be capitalized. Costs incurred during the preliminary project design along with post-implementation stages of internal use software are expensed as incurred and included in research and development in the statements of income.
Goodwill and Impairment of Long-Lived Assets
Goodwill
Goodwill represents the excess of the purchase price over the fair value of net assets acquired in a business combination. We test goodwill for impairment in accordance with the provisions of ASC 350, Intangibles – Goodwill and Other, (“ASC 350”). Goodwill is tested for impairment at least annually at the reporting unit level or whenever events or changes in circumstances indicate that goodwill might be impaired. ASC 350 provides that an entity has the option to first assess qualitative factors to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the fair value of a reporting unit is less than its carrying amount.
The events and circumstances we consider in performing the qualitative assessment include macroeconomic conditions, industry and market considerations, overall financial performance of the reporting units and other relevant entity-specific events. If, after assessing the totality of events or circumstances, an entity determines that it is more likely than not that the fair value of a reporting unit is equal to or exceeds its carrying value, then additional impairment testing is not required. However, if an entity concludes otherwise, then it is required to perform an impairment test, which involves comparing the estimated fair value of a reporting unit with its book value, including goodwill. To estimate the fair value of the reporting unit for the impairment test, the entity can use an income approach, a market approach, or a combination of both. If the estimated fair value exceeds book value, goodwill is not considered to be impaired. If, however, the estimated fair value of a reporting unit is less than its book value, then we recognize an impairment loss equal to the amount that the book value of the reporting unit exceeds its estimated fair value, not to exceed the total amount of goodwill allocated to the reporting unit.
We monitor the indicators for goodwill impairment between annual tests. During the three months ended June 30, 2024 and 2023, we did not recognize an impairment loss for goodwill.
Impairment of Long-Lived Assets
The Company evaluates its long-lived assets, including property, equipment and intangible assets (other than goodwill) for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset might not be recoverable. We determine whether the carrying value of an asset or asset group is recoverable, based on comparisons to undiscounted expected future cash flows we expect the asset or asset group to generate. If an asset is not recoverable, we record an impairment loss equal to the amount by which the carrying value of the asset exceeds its fair value. During the three months ended June 30, 2024 and 2023, we did not recognize an impairment loss to our long-lived and intangible assets.
Income Taxes
Income Taxes
We utilize the asset and liability method of accounting for income taxes, under which deferred taxes are determined based on the temporary differences between the financial statement and tax basis of assets and liabilities using tax rates expected to be in effect during the years in which the basis differences reverse. A valuation allowance is recorded when it is more-likely-than-not that some or all of the deferred tax assets will not be realized, which increases our income tax expense in the period such determination is made. As such, as of June 30, 2024, we determined it was appropriate to record a full valuation allowance against our deferred tax assets. We will continuously reassess the appropriateness of maintaining a valuation allowance. We intend to continue maintaining a full valuations allowance on our deferred tax assets until there is sufficient evidence to support the reversal of all or some portion of these allowances. However, given our current earnings and anticipated future earnings, we believe that there is a reasonable possibility that within the next twelve months, sufficient positive evidence may become available to allow us to reach a conclusion that a significant portion of the valuation allowance will no longer be needed. Release of the valuation allowance would result in the recognition of certain deferred tax assets and a decrease to income tax expense for the period the release is recorded. However, the exact timing and amount of the valuation allowance release are subject to change on the basis of the level of profitability that we are able to actually achieve.
Income tax positions must meet a more-likely-than-not recognition threshold to be recognized. Income tax positions that previously failed to meet the more-likely-than-not threshold are recognized in the first subsequent financial reporting period in which that threshold is met. Previously recognized tax positions that no longer meet the more-likely-than-not threshold are derecognized in the first subsequent financial reporting period in which that threshold is no longer met.
Stock-Based Compensation
Stock-Based Compensation
We record stock-based compensation in our unaudited condensed statements of income as an expense, based on the estimated grant date fair value of our stock-based awards, whereby such fair values are amortized over the requisite service period. Our stock-based awards currently comprise common stock options, restricted stock units and performance stock units. The fair value of our common stock option awards is estimated on the grant date using the Black-Scholes-Merton option-pricing formula. The fair value of our performance stock unit awards is estimated on the grant date using a Monte Carlo simulation model. While the use of these models meets established requirements, the estimated fair values generated by the models might not be indicative of the actual fair values of our awards as it does not consider certain factors important to those awards to employees, such as continued employment and periodic vesting requirements, as well as limited transferability. The fair value of our restricted stock units is based on the closing market price of our common stock on the grant date. If there are any modifications or cancellations of the underlying unvested stock-based awards, we may be required to accelerate, increase or cancel any remaining unearned stock-based compensation expense.
Research and Development Expenditures
Research and Development Expenditures
We expense research and development expenditures in the period incurred.
Shipping and Handling Costs
Shipping and Handling Costs
We include shipping and handling costs in the cost of revenues in the period during which the products ship.
Sales Taxes
Sales Taxes
We present sales taxes on a net basis (excluded from revenues) in the statements of income.
Right-of-Use Assets and Lease Liabilities
Right-of-Use Assets and Lease Liabilities
We determine if an arrangement contains a lease at inception and classify the lease as either an operating or finance lease at its commencement.
Right-of-use assets and lease liabilities are recorded based on the present value of future lease payments, which factors in certain qualifying initial direct costs incurred as well as any lease incentives received. If an implicit rate is not readily determinable, we utilize inputs from third-party lenders to determine the appropriate discount rate. Lease expense for operating lease payments is recognized on a straight-line basis over the lease term. Finance leases incur interest expense using the effective interest method in addition to amortization of the leased asset on straight-line basis, both over the applicable lease term. Lease terms may factor in options to extend or terminate the lease.
We adhere to the short-term lease recognition exemption for all classes of assets (i.e., facilities and equipment). As a result, leases with an initial term of twelve months or less are not recorded on the balance sheet and are recognized on a straight-line basis over the lease term. In addition, for certain equipment leases, we account for lease and non-lease components, such as services, as a single lease component as permitted.
Warranty
Warranty
We generally provide a two- to three-year warranty on materials and workmanship from the original invoice date on all products manufactured by the Company. Products sold to various original equipment manufacturer customers sometimes carry longer warranties. We will either repair or replace defective products, usually at our option, upon meeting certain criteria. We accrue a provision for the estimated costs that may be incurred for product warranties relating to a product as a component of cost of sales at the time revenues for that product is recognized. The accrued warranty reserve is included within accrued liabilities in the accompanying unaudited condensed balance sheets. We do not provide any service-type warranties.
Repair and Maintenance Costs
Repair and Maintenance Costs
We incur repair and maintenance costs in the normal course of business. Should the repair or maintenance result in a permanent improvement to one of our leased facilities, the cost is capitalized as a leasehold improvement and amortized over its useful life or the remainder of the lease period, whichever is shorter. Non-permanent repair and maintenance costs are expensed as incurred.
Loss Contingencies
Loss Contingencies
We are subject to legal actions that arise in the ordinary course of business. The Company recognizes a liability for a contingency when it is probable that liability has been incurred and when the amount of loss can be reasonably estimated. When a range of probable loss can be estimated, the Company accrues the most likely amount of such loss at no less than the minimum of the range. The Company expenses legal defense costs as incurred.
Comprehensive Income (Loss)
Comprehensive Income
Net income was the same as comprehensive income for the three months ended June 30, 2024 and 2023.
Recent Accounting Pronouncements
Recent Accounting Pronouncements
In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280), which is intended to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant expenses. This ASU is applicable to our Annual Report on Form 10-K for the fiscal year ending March 31, 2025, and subsequent interim periods. Early adoption is permitted and the amendments in this ASU should be applied retroactively. We are currently evaluating the impact of this ASU on our financial statement disclosures.
In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740), which includes amendments that further enhance income tax disclosures, primarily through standardization and disaggregation of rate reconciliation categories and income taxes paid by jurisdictions. This ASU is applicable to our Annual Report on Form 10-K for the fiscal year ending March 31, 2026. Early adoption is permitted and the amendments in this ASU should be applied prospectively. Retrospective application is permitted. We are currently evaluating the impact of this ASU on our financial statement disclosures.
v3.24.2.u1
Description of Business and Summary of Significant Accounting Policies (Tables)
3 Months Ended
Jun. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Typical Performance Obligations
The Company’s typical performance obligations include the following:
Performance Obligation
When Performance
Obligation is Typically
Satisfied
When Payment is
Typically Due
How Standalone
Selling Price is
Typically Estimated
Product Revenues
Standard purchase orders for delivery of a tangible product
Upon shipment (point in time)
Within 30 days of delivery
Observable transactions
Engineering services where the deliverable is considered a product
As work is performed (over time)
Within 30 days of services being invoiced
Estimated using a cost-plus margin approach
Service Revenues
Engineering, managed services, and consulting services
As work is performed (over time)
Within 30 days of services being invoiced
Estimated using a cost-plus margin approach
SaaS
Over the course of the SaaS service once the system is available for use (over time)
At the beginning of the contract period
Estimated using a cost-plus margin approach
Extended warranty serviceOver the course of the extended warranty period (over time)
At the beginning of the contract period
Estimated using a cost-plus margin approach
Schedule of Cash, Cash Equivalents and Restricted Cash
Cash, cash equivalents and restricted cash presented in the accompanying unaudited condensed statements of cash flows consisted of the following:
June 30,
20242023
(In thousands)
Cash and cash equivalents$21,377 $19,994 
Restricted cash248 274 
$21,625 $20,268 
v3.24.2.u1
Supplemental Financial Information (Tables)
3 Months Ended
Jun. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Inventories
The following table presents details of our inventories, net:
June 30,
2024
March 31,
2024
(In thousands)
Raw materials$11,514 $9,063 
Work in process185 468 
Finished goods3,142 3,901 
$14,841 $13,432 
Schedule of Property And Equipment, Net
The following table presents details of our property and equipment, net:
June 30,
2024
March 31,
2024
(In thousands)
Equipment$6,968 $6,871 
Leasehold improvements858 828 
Accumulated depreciation(6,538)(6,403)
$1,288 $1,296 
Schedule of Net Intangible Assets The following table presents details of our net intangible assets:
June 30, 2024March 31, 2024
Gross
Carrying
Amount
Accumulated
Amortization
Net Book
Value
Gross
Carrying
Amount
Accumulated
Amortization
Net Book
Value
(In thousands)
Technology$5,029 $(4,601)$428 $5,009 $(4,369)$640 
Customer contracts / relationships9,550 (6,136)3,414 9,550 (5,783)3,766 
Trade names and non-compete agreements782 (770)12 782 (770)12 
Capitalized software development costs10,315 (5,378)4,937 10,164 (4,980)5,184 
Total$25,676 $(16,885)$8,791 $25,505 $(15,902)$9,602 
Schedule of Future Estimated Amortization Expense
As of June 30, 2024, future estimated amortization expense was as follows:
Year Ending March 31,
(In thousands)
2025$2,586 
20262,359 
20272,036 
20281,295 
2029503 
$8,779 
Schedule of Warranty Reserve Activity The following table presents activity related to the warranty reserve:
Three Months Ended
June 30,
20242023
(In thousands)
Balance at beginning of fiscal year$813 $758 
Additions charged to cost of sales48 193 
Warranty claims(5)(96)
Balance at end of reporting period$856 $855 
Schedule of Computation of Basic and Diluted Net Loss Per Share
The following table sets forth the computation of basic and diluted net income per share:
Three Months Ended
June 30,
20242023
(In thousands, except per share amounts)
Numerator:
Net income$392 $2,125 
Denominator:
Weighted average common shares used in basic computation42,969 42,567 
Stock options and other dilutive awards1,001 1,073 
Weighted average common shares used in diluted computation43,970 43,640 
Net income per common share
     Basic net income per share $0.01 $0.05 
     Diluted net income per share $0.01 $0.05 
Schedule of Instruments Excluded in the Computation of Diluted Net Loss Per Share
The following instruments were excluded for purposes of calculating weighted average common share equivalents in the computation of diluted net income per share as their effect would have been anti-dilutive:
Three Months Ended
June 30,
20242023
(In thousands)
Stock options3,677 3,362 
Restricted stock units18 280 
v3.24.2.u1
Fair Value Measurements (Tables)
3 Months Ended
Jun. 30, 2024
Fair Value Disclosures [Abstract]  
Schedule of Financial Assets that are Recorded at Fair Value on a Recurring Basis
The following tables present the Company’s financial assets and liabilities that are recorded at fair value on a recurring basis, segregated among the appropriate levels within the fair value hierarchy:
As of June 30, 2024
Amortized
Cost
Gross
Unrealized
Loss
Gross
Unrealized
Gain
Estimated Fair
Value
(In thousands)
Assets:
Level 1:
Securities held in deferred compensation plan (1)
$1,461 $(681)$843 $1,623 
Liabilities:
Level 1:
Deferred compensation plan liabilities (2)
$1,474 $(535)$702 $1,641 
As of March 31, 2024
Amortized
Cost
Gross
Unrealized
Loss
Gross
Unrealized
Gain
Estimated Fair
Value
(In thousands)
Assets:
Level 1:
Securities held in deferred compensation plan (1)
$1,539 $(542)$650 $1,647 
Liabilities:
Level 1:
Deferred compensation plan liabilities (2)
$1,415 $(485)$633 $1,563 
(1) Included in prepaid expenses and other current assets on the Company’s balance sheets.
(2) Included in accrued payroll and related expenses on the Company’s balance sheets.
v3.24.2.u1
Right-of-Use Assets and Lease Liabilities (Tables)
3 Months Ended
Jun. 30, 2024
Lessee Disclosure [Abstract]  
Schedule of Lease-related Assets and Liabilities Recorded on the Unaudited Condensed Consolidated Balance Sheet
The table below presents lease-related assets and liabilities recorded on the unaudited condensed balance sheet as follows:
ClassificationJune 30, 2024March 31, 2024
(In thousands)
Assets
Operating lease right-of-use-assetsRight-of-use assets$6,827 $7,237 
Total operating lease right-of-use-assets$6,827 $7,237 
Liabilities
Operating lease liabilities (short-term)Accrued liabilities$2,176 $2,233 
Operating lease liabilities (long-term)Lease liabilities5,857 6,210 
Total lease liabilities$8,033 $8,443 
Schedule of Supplemental Information Related to Operating Leases
Information related to the Company right-of-use assets and related operating lease liabilities were as follows:
Three Months Ended
June 30,
(Dollars in thousands)
20242023
Cash paid for amounts included in the measurement of operating lease liabilities $815$673
Weighted average remaining lease term (in years)3.523.90
Weighted average discount rate5.0 %4.7 %
Schedule of Undiscounted Cash Flows
The table below reconciles the undiscounted cash flows for each of the next five years and the total of the remaining years to the operating lease liabilities recorded on the balance sheet as of June 30, 2024:
Fiscal Year Ending March 31,Operating Leases
(In thousands)
2025$1,931 
20262,436 
20262,498 
20281,447 
2029293 
Thereafter188 
Total lease payments8,793 
Less imputed interest(760)
Present value of future lease payments8,033 
Less current obligations under leases(2,176)
Long-term lease obligations$5,857 
v3.24.2.u1
Stock-Based Compensation (Tables)
3 Months Ended
Jun. 30, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Activity With Respect to Stock Options
A summary of activity with respect to our stock options for the three months ended June 30, 2024 is as follows:
SharesWeighted-
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Life
Aggregate
Intrinsic
Value
(In thousands)(Years)(In thousands)
Options outstanding at March 31, 20245,858 $4.11 
Granted369 4.21 
Exercised(3)3.47 
Forfeited(67)4.02 
Expired(3)4.79 
Options outstanding at June 30, 20246,154 4.12 5.4$3,484 
Options vested and exercisable at June 30, 20244,267 4.15 4.0$2,647 
Schedule of Activity With Respect to RSUs
A summary of activity with respect to our RSUs, which entitle the holder to receive one share of our common stock for each RSU upon vesting, for the three months ended June 30, 2024 is as follows:
SharesWeighted-Average
Grant Date
Fair Value
(In thousands)
RSUs outstanding at March 31, 2024793 $4.18 
Granted110 4.27 
Vested and released— — 
Forfeited(24)3.49 
RSUs outstanding at June 30, 2024879 4.21 
Schedule of Activity With Respect to PSUs
The following table summarizes the details of the performance stock units:
SharesWeighted-Average
Grant Date
Fair Value
(In thousands)
PSUs outstanding at March 31, 2024117 $4.75 
Granted83 4.55 
Vested and released(31)5.02 
Forfeited(14)6.16 
PSUs outstanding at June 30, 2024155 4.43 
Schedule of Stock-based Compensation Expense
The following table presents stock-based compensation expense that is included in each line item on our unaudited condensed statements of income:
Three Months Ended
June 30,
20242023
(In thousands)
Cost of revenues$89 $85 
General and administrative361 202 
Sales and marketing55 134 
Research and development90 104 
Total stock-based compensation$595 $525 
v3.24.2.u1
Description of Business and Summary of Significant Accounting Policies - Revenue Recognition (Details)
$ in Millions
3 Months Ended
Jun. 30, 2024
USD ($)
segment
Mar. 31, 2024
USD ($)
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Capitalized contract fulfillment costs | $ $ 0.4 $ 0.5
Number of operating segments 1  
Number of reportable segments 1  
v3.24.2.u1
Description of Business and Summary of Significant Accounting Policies - Deferred Revenues (Details) - USD ($)
$ in Millions
Jun. 30, 2024
Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Long-term deferred revenues $ 4.0 $ 3.4
v3.24.2.u1
Description of Business and Summary of Significant Accounting Policies - Concentration of Credit Risk (Details)
$ in Millions
Jun. 30, 2024
USD ($)
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Deposits in excess of FDIC insured limit $ 21.1
v3.24.2.u1
Description of Business and Summary of Significant Accounting Policies - Cash, Cash Equivalents and Restricted Cash (Details) - USD ($)
$ in Thousands
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2023
Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]        
Cash and cash equivalents $ 21,377 $ 25,850 $ 19,994  
Restricted cash 248 125 274  
Cash, cash and cash equivalents and restricted cash $ 21,625 $ 25,975 $ 20,268 $ 16,727
v3.24.2.u1
Description of Business and Summary of Significant Accounting Policies - Property and Equipment (Details) - Property and Equipment
Jun. 30, 2024
Minimum  
Significant accounting policies  
Useful life 2 years
Maximum  
Significant accounting policies  
Useful life 8 years
v3.24.2.u1
Description of Business and Summary of Significant Accounting Policies - Goodwill and Long-Lived Assets (Details)
3 Months Ended
Jun. 30, 2024
segment
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Number of operating segments 1
Number of reportable segments 1
v3.24.2.u1
Description of Business and Summary of Significant Accounting Policies - Warranty (Details)
Jun. 30, 2024
Minimum  
Significant accounting policies  
Product warranty obligation, term 2 years
Maximum  
Significant accounting policies  
Product warranty obligation, term 3 years
v3.24.2.u1
Supplemental Financial Information - Inventories (Details) - USD ($)
$ in Thousands
Jun. 30, 2024
Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Raw materials $ 11,514 $ 9,063
Work in process 185 468
Finished goods 3,142 3,901
Total inventories $ 14,841 $ 13,432
v3.24.2.u1
Supplemental Financial Information - Property and Equipment (Details) - USD ($)
$ in Thousands
Jun. 30, 2024
Mar. 31, 2024
Property and Equipment, net    
Accumulated depreciation $ (6,538) $ (6,403)
Property and equipment, net 1,288 1,296
Equipment    
Property and Equipment, net    
Gross 6,968 6,871
Leasehold Improvements    
Property and Equipment, net    
Gross $ 858 $ 828
v3.24.2.u1
Supplemental Financial Information - Narrative (Details) - USD ($)
$ in Thousands
3 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]      
Depreciation $ 135 $ 150  
Goodwill 28,340   $ 28,340
Intangible Assets      
Amortization of intangible assets 982 783  
Cost of revenues      
Intangible Assets      
Amortization of intangible assets 300 100  
Operating expenses      
Intangible Assets      
Amortization of intangible assets $ 700 $ 700  
v3.24.2.u1
Supplemental Financial Information - Intangible Assets (Details) - USD ($)
$ in Thousands
Jun. 30, 2024
Mar. 31, 2024
Intangible Assets    
Gross Carrying Amount $ 25,676 $ 25,505
Accumulated Amortization (16,885) (15,902)
Net Book Value 8,791 9,602
Technology    
Intangible Assets    
Gross Carrying Amount 5,029 5,009
Accumulated Amortization (4,601) (4,369)
Net Book Value 428 640
Customer contracts / relationships    
Intangible Assets    
Gross Carrying Amount 9,550 9,550
Accumulated Amortization (6,136) (5,783)
Net Book Value 3,414 3,766
Trade names and non-compete agreements    
Intangible Assets    
Gross Carrying Amount 782 782
Accumulated Amortization (770) (770)
Net Book Value 12 12
Capitalized software development costs    
Intangible Assets    
Gross Carrying Amount 10,315 10,164
Accumulated Amortization (5,378) (4,980)
Net Book Value $ 4,937 $ 5,184
v3.24.2.u1
Supplemental Financial Information - Future Estimated Amortization Expense (Details)
$ in Thousands
Jun. 30, 2024
USD ($)
Future estimated amortization expense  
2025 $ 2,586
2026 2,359
2027 2,036
2028 1,295
2029 503
Net Book Value $ 8,779
v3.24.2.u1
Supplemental Financial Information - Warranty Reserve Activity (Details) - USD ($)
$ in Thousands
3 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Activity related to warranty reserve    
Balance at beginning of fiscal year $ 813 $ 758
Additions charged to cost of sales 48 193
Warranty claims (5) (96)
Balance at end of reporting period $ 856 $ 855
v3.24.2.u1
Supplemental Financial Information - Earnings (Loss) Per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Numerator:    
Net income (loss) $ 392 $ 2,125
Denominator:    
Weighted average common shares used in basic computation (in shares) 42,969 42,567
Stock options and other dilutive awards (in shares) 1,001 1,073
Weighted average common shares used in diluted computation (in shares) 43,970 43,640
Net income per common share    
Basic net income per share (in dollars per share) $ 0.01 $ 0.05
Diluted net income per share (in dollars per share) $ 0.01 $ 0.05
v3.24.2.u1
Supplemental Financial Information - Loss per Share Excluded Weighted Average (Details) - shares
shares in Thousands
3 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Stock options    
Shares excluded in the computation of loss from continuing operations per share    
Shares excluded in the computation of loss from continuing operations per share 3,677 3,362
Restricted stock units    
Shares excluded in the computation of loss from continuing operations per share    
Shares excluded in the computation of loss from continuing operations per share 18 280
v3.24.2.u1
Fair Value Measurements - Narrative (Details) - USD ($)
Jun. 30, 2024
Mar. 31, 2024
Fair Value Disclosures [Abstract]    
Non-financial assets measured at fair value $ 0 $ 0
v3.24.2.u1
Fair Value Measurements (Details) - Level 1: - USD ($)
$ in Thousands
Jun. 30, 2024
Mar. 31, 2024
Securities Held In Deferred Compensation Plan    
Assets:    
Amortized Cost $ 1,461 $ 1,539
Gross Unrealized Loss (681) (542)
Gross Unrealized Gain 843 650
Estimated Fair Value 1,623 1,647
Deferred Compensation Plan Liabilities    
Liabilities:    
Amortized Cost 1,474 1,415
Gross Unrealized Loss (535) (485)
Gross Unrealized Gain 702 633
Estimated Fair Value $ 1,641 $ 1,563
v3.24.2.u1
Income Taxes (Details) - USD ($)
$ in Thousands
3 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Reconciliation of income tax (benefit) provision to taxes computed at U.S. federal statutory rates    
Income tax expense (benefit) $ 48 $ 95
Effective income tax rate 10.90% 4.30%
v3.24.2.u1
Commitments and Contingencies (Details) - USD ($)
$ in Millions
3 Months Ended
Aug. 07, 2023
Jun. 30, 2023
Commitments and Contingencies Disclosure [Abstract]    
Inventory return amount $ 0.8 $ 1.0
Loss contingency   0.2
Inventory sale amount   $ 1.0
v3.24.2.u1
Right-of-Use Assets and Lease Liabilities - Narrative (Details) - USD ($)
$ in Millions
3 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Lease Costs    
Lease costs $ 0.6 $ 0.6
Minimum    
Operating Leases    
Renewal option term 1 year  
Maximum    
Operating Leases    
Renewal option term 5 years  
v3.24.2.u1
Right-of-Use Assets and Lease Liabilities - Related Assets and Liabilities on the Balance Sheet (Details) - USD ($)
$ in Thousands
Jun. 30, 2024
Mar. 31, 2024
Assets    
Operating lease right-of-use-assets $ 6,827 $ 7,237
Liabilities    
Operating lease liabilities (short-term) $ 2,176 $ 2,233
Operating lease, liability, current, statement of financial position Accrued liabilities Accrued liabilities
Operating lease liabilities (long-term) $ 5,857 $ 6,210
Total lease liabilities $ 8,033 $ 8,443
v3.24.2.u1
Right-of-Use Assets and Lease Liabilities - Supplemental Information (Details) - USD ($)
$ in Thousands
3 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Supplemental Information    
Cash paid for amounts included in the measurement of operating lease liabilities $ 815 $ 673
Weighted average remaining lease term (in years) 3 years 6 months 7 days 3 years 10 months 24 days
Weighted average discount rate 5.00% 4.70%
v3.24.2.u1
Right-of-Use Assets and Lease Liabilities - Undiscounted Cash Flows (Details) - USD ($)
$ in Thousands
Jun. 30, 2024
Mar. 31, 2024
Operating Leases    
2024 $ 1,931  
2026 2,436  
2026 2,498  
2028 1,447  
2029 293  
Thereafter 188  
Total lease payments 8,793  
Less imputed interest (760)  
Total lease liabilities 8,033 $ 8,443
Less current obligations under leases (2,176) (2,233)
Long-term lease obligations $ 5,857 $ 6,210
v3.24.2.u1
Stock-Based Compensation - Stock Options (Details)
$ / shares in Units, $ in Thousands
3 Months Ended
Jun. 30, 2024
USD ($)
plan
$ / shares
shares
Stock-Based Compensation  
Number of stock incentive plans | plan 2
Vested and expected to vest at the end of the period (in shares) 6,200,000
Stock options  
Shares  
Options outstanding at the beginning of the period (in shares) 5,858,000
Granted (in shares) 369,000
Exercised (in shares) (3,000)
Forfeited (in shares) (67,000)
Expired (in shares) (3,000)
Options outstanding at the end of the period (in shares) 6,154,000
Option vested and exercisable at the end of the period (in shares) 4,267,000
Weighted- Average Exercise Price  
Options outstanding at the beginning of the period (in dollars per share) | $ / shares $ 4.11
Granted (in dollars per share) | $ / shares 4.21
Exercised (in dollars per share) | $ / shares 3.47
Forfeited (in dollars per share) | $ / shares 4.02
Expired (in dollars per share) | $ / shares 4.79
Options outstanding at the end of the period (in dollars per share) | $ / shares 4.12
Option vested and exercisable at the end of the period (in dollars per share) | $ / shares $ 4.15
Weighted Average Remaining Contractual Life  
Options outstanding at the end of the period (in years) 5 years 4 months 24 days
Option vested and exercisable at the end of the period (in years) 4 years
Aggregate Intrinsic Value  
Options outstanding at the end of the period | $ $ 3,484
Option vested and exercisable at the end of the period | $ $ 2,647
2016 Plan  
Stock-Based Compensation  
Authorized for future issuance under stock incentive plans (in shares) 1,100,000
v3.24.2.u1
Stock-Based Compensation - Restricted Stock Units (Details) - Restricted stock units
3 Months Ended
Jun. 30, 2024
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Number of shares of common stock receivable upon vesting of each RSU (in shares) 1
Shares  
Options outstanding at the beginning of the period (in shares) 793,000
Granted (in shares) 110,000
Vested (in shares) 0
Forfeited (in shares) (24,000)
Options outstanding at the end of the period (in shares) 879,000
Weighted-Average Grant Date Fair Value  
Options outstanding at the beginning of the period (in dollars per share) | $ / shares $ 4.18
Granted (in dollar per share) | $ / shares 4.27
Vested (in dollars per share) | $ / shares 0
Forfeited (in dollars per share) | $ / shares 3.49
Options outstanding at the end of the period (in dollars per share) | $ / shares $ 4.21
v3.24.2.u1
Stock-Based Compensation - Performance Stock Units (Details) - Performance Stock Units
shares in Thousands
3 Months Ended
Jun. 30, 2024
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Maximum achievement percentage 200.00%
Performance period 3 years
Service period 3 years
Shares  
Options outstanding at the beginning of the period (in shares) | shares 117
Granted (in shares) | shares 83
Vested (in shares) | shares (31)
Forfeited (in shares) | shares (14)
Options outstanding at the end of the period (in shares) | shares 155
Weighted-Average Grant Date Fair Value  
Options outstanding at the beginning of the period (in dollars per share) | $ / shares $ 4.75
Granted (in dollar per share) | $ / shares 4.55
Vested (in dollars per share) | $ / shares 5.02
Forfeited (in dollars per share) | $ / shares 6.16
Options outstanding at the end of the period (in dollars per share) | $ / shares $ 4.43
Minimum  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Maximum achievement percentage 0.00%
Vesting percentage 0.00%
Performance modifier 0.75
Maximum  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Maximum achievement percentage 200.00%
Vesting percentage 160.00%
Performance modifier 1.25
v3.24.2.u1
Stock-Based Compensation - Stock Based Compensation Expense (Details) - USD ($)
$ in Thousands
3 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Stock-Based Compensation    
Total stock-based compensation $ 595 $ 525
Stock options    
Stock-Based Compensation    
Unrecognized compensation expense related to unvested stock options $ 3,300  
Weighted average period over which compensation expense is expected to be recognized 2 years 7 months 6 days  
Restricted stock units    
Stock-Based Compensation    
Unrecognized compensation expense related to unvested RSUs $ 1,800  
Weighted average period over which compensation expense is expected to be recognized 1 year 8 months 12 days  
Phantom Share Units (PSUs)    
Stock-Based Compensation    
Unrecognized compensation expense related to unvested RSUs $ 500  
Weighted average period over which compensation expense is expected to be recognized 2 years 1 month 6 days  
Cost of revenues    
Stock-Based Compensation    
Total stock-based compensation $ 89 85
General and administrative    
Stock-Based Compensation    
Total stock-based compensation 361 202
Sales and marketing    
Stock-Based Compensation    
Total stock-based compensation 55 134
Research and development    
Stock-Based Compensation    
Total stock-based compensation $ 90 $ 104
v3.24.2.u1
Stock-Based Compensation - Other Stock-Based Compensation Plans (Details) - ESPP
$ in Thousands
3 Months Ended
Jun. 30, 2024
USD ($)
offering_period
Other Stock-Based Compensation Plans  
Purchase price of common stock 95.00%
Number of offering periods | offering_period 2
Duration of offering period 6 months
Annual stock value | $ $ 30
Minimum  
Other Stock-Based Compensation Plans  
Employer matching contribution 1.00%
Maximum  
Other Stock-Based Compensation Plans  
Employer matching contribution 15.00%
v3.24.2.u1
Stock-Based Compensation - Deferred Compensation Plan (Details)
Oct. 01, 2020
plan
Share-Based Payment Arrangement [Abstract]  
Number of deferred compensation plans 2
v3.24.2.u1
Stock Repurchase Program (Details) - May 2022 Program - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 26 Months Ended
Jun. 30, 2024
Jun. 30, 2024
May 12, 2022
Stock Repurchase Program      
Value of common stock approved under stock repurchase program     $ 10.0
Number of shares acquired 146,541 486,402  
Value of common stock repurchased $ 0.6 $ 1.7  
Average price per share of common stock repurchased (in dollars per share) $ 4.24 $ 3.47  
Share repurchase program, authorized, number of shares 339,861 339,861  
Value of common stock available for repurchase under current program $ 8.3 $ 8.3  
v3.24.2.u1
Business Segments (Details)
3 Months Ended
Jun. 30, 2024
segment
Segment Reporting [Abstract]  
Number of operating segments 1
Number of reportable segments 1

Iteris (NASDAQ:ITI)
過去 株価チャート
から 7 2024 まで 8 2024 Iterisのチャートをもっと見るにはこちらをクリック
Iteris (NASDAQ:ITI)
過去 株価チャート
から 8 2023 まで 8 2024 Iterisのチャートをもっと見るにはこちらをクリック